Author Index
AAban I. PE7.4/5
Abongomera G. PE4.3/2
Aboud M. PE3.5/3
Aboulker J.-P. PE1.4/3, PE3.2/2,
PE7.2/2
Abril V. PE18.5/6, PE9.1/2
Abutidze A. PE17.2/1
Achenbach S. PE9.5/7
ACHIEV2E Study Group PE1.4/2, PS10/5
Acinapura R.A. PE10.1/10
Acquaviva V. PE9.6/1
Adams L.V. PE9.3/1
Adda A. PE7.2/3
Adekoya P. PE20.4/1
Adermann K. PS10/4
Adje C. PE9.1/1
Adorni F. PE9.6/1
Aggett S. PE19.1/3
Agher R. PE7.2/5
Ahmad I.F. PE3.5/2
Aigbomian D. PE20.4/1
Airoldi M. PE10.1/3
Ait Mohand H. PE13.2/7, PE9.8/2
Ajana F. PE9.1/3
Akatova N. PS9/2
Akuma S.H. PE4.3/1
Aldir I. PE20.4/6
Alfaiate D.P. PE20.4/6
Alfayate R. PE9.2/2
Allavena C. PE7.9/1, PE7.9/15,
PE7.9/17, PE7.9/18,
PE9.1/3, LBPS10/6
Almeida C.-A. PE3.5/2
ALTAIR Study Group PE2.7/1
Alteri C. PE17.2/2
Alvarez M. PE1.2/1, PE1.2/7
Alves H. PE12.5/2
AMACS PE7.9/23
Amalin W. PE19.7/1
Amendola A. PE10.1/11
Amiel C. PE3.1/4, PE3.4/2,
PE7.2/3, PS12/3
Amin J. PE7.9/11, PS10/2
Ammassari A. PE10.1/10, PE10.1/11,
PE18.4/4, PE19.3/1
Amornnimit W. PE7.9/14
Anadol E. PE13.3/1, PE13.5/1
Anceau A. PE19.5/2
Anderson J. BPD1/6, PE10.4/1
Andrade R.M. PE7.2/6
Andrade-Villanueva J. PE7.3/11, PS10/3,
PS4/3
Andre-Garnier E. PE7.9/15
Andreoni M. PE7.5/2
Anema A. LBPE18.5/8
Angeletti C. PE10.4/6, PE19.3/1
Annemans L. PE19.5/5
ANRS 127 Trial Study
Group PE3.2/2
ANRS AC11 Resistance
Study Group PS12/3, PS12/4
ANRS C08 APROCO-
COPILOTE Study Group LBPS6/7
Antela A. PE7.9/9
Antinori A. LS2/2, PE10.1/10,
PE10.1/11, PE10.1/3,
PE10.4/6, PE18.4/4,
PE19.3/1, PE3.4/10,
PE9.5/8
Antinori S. PE9.6/1
Anton E. PE1.2/2
Antonelli G. PE13.4/4
Antoniadou A. PE3.1/5, PE7.9/23
Antonucci G. PS2/5
Antunes F. PE18.5/5, PE7.3/11,
PS2/2
Arama S.S. PE9.2/4
Arama V. PE11.6/4, PE9.2/4
Aranzabal L. PE9.6/5
Arasteh K. PE11.4/1, PS3/4
Arasteh K. PE4.1/2
Araujo C. PE20.7/1
Arbune M. PE13.1/10
Arendt G. PE6.9/1
Argirova R. PE6.1/1, PS3/6
Arinze F.N. PE19.4/1, PE20.4/4
Arranz Caso A. PE11.6/2
Arranz J.A. PE9.8/1
Arribas J. PE3.4/1, PE7.5/4,
PS4/1
Arribas J.R. BPD2/3, PS10/1,
PS4/6
Arroita Gonzalez G. PE10.1/6
Arroyo-Anduiza C.I. PE13.1/11
Arsova Netzelmann T. PE20.4/5
Arzouk N. PE10.4/7
Asher I. PE10.1/2, PE9.7/6
Assaad H. BPD2/1
Assami H. PE7.2/3
Assel M. PE3.1/8
ASSERT Team PS10/1
Assoumou L. PS12/2
Atamasirikul K. PE13.1/3
Ateka G.K. PE14.9/1
Athmann C. PE9.7/3
Atoui N. PE9.9/1
Aufray E. PE9.9/1
Au-Yeung C.G. LBPE18.5/8
Avettand-Fenoel V. PE1.4/1
Avihingsanon A. PS2/1
Awni W.A. PE4.1/4
Ayoub A. LBPE13.2/10
Azzena G. PE12.3/1
BBabiel R. PE1.4/1
Bachabi M. PE19.7/1
Bacheler L. PE3.2/1, PE3.3/4
Bachiller P. PE7.9/9
Back D. PE4.3/2, PS12/5,
PS12/6
Back D.J. PE4.1/7
Badsi E. PE13.1/4
Bagnis C.I. PE18.1/4
Bai F. PE10.1/3, PE9.10/1
Baietto L. PE4.1/7
Bailey G. PE7.1/4
Bakari M. PE9.3/1
Baker D. PE7.9/11
Bakowska E. PE9.6/3
Bakoyannis G. PE7.9/23
Baldelli F. PE3.4/7, PE9.7/5
Baldelli S. LBPE4.3/5
Balduin M. PE3.5/4
Ballester E. PE18.5/6, PE9.1/2
Ballestri S. PS11/3
Balogh A. PE7.9/19
Balotta C. PS10/5
Banhegyi D. PE8.1/1
Bannister W. PE3.1/1, PS8/6
Bansi L. PE3.1/8
Baran R.W. PE10.4/3
Barata A. PE18.1/6
Barber T.J. PE10.4/1
Barbai V.H. PE8.1/1
Barcena R. PE7.9/8
Barda B. PE9.2/5
Bar-Magen T. PE3.4/4
Baros S. PE19.9/2
Barquilla E. PE7.9/2
Barreiro P. PE7.9/12
Barrou B. PE10.4/7
Barrufet P. BPD2/6
Bartmeyer B. PE7.4/7
Bary M. PE9.3/5, PE9.7/7
BASIC Study Group LBPS10/6
Basioni Stamenic F. PE19.9/2
Bastard J.-P. LBPS6/7
Battegay M. PE7.4/1, PS12/5,
PS2/3, PS5/2,
LBPS5/7
Battegay M.E. PE4.1/2
Batzing-Feigenbaum J. LBBPD1/3, PE16.6/1
Baudewig M. PE18.4/5
Baumgarten A. PE13.2/3, PE13.2/4,
PE13.2/9, PE3.3/3,
PE7.9/19, PE7.9/20,
PS2/4
Bbosa G. PE19.9/1
Beatrice J. PE7.9/22
Beckebaum S. PE13.5/1
Begovac J. PS6/6
Beguinot I. PE4.1/5
Behrendt D. PS2/4
Behrens G.M. PE9.3/3
Belfiori B. PE9.7/5
Belgian HIV Cohort PE7.7/2
Bellagamba R. PE19.3/1
Bellon J.M. PS9/3, PS9/5
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
222 Author Index
Ben Amor K. PE8.3/1
Ben-Abdallah S. PE10.4/7, PE9.8/2
Benalycherif A. PE7.5/5
Benard A. PE1.4/2
Benard A. PS10/5
Bencini A. PE1.2/8
Bender C. LBPE13.5/2
Benea O. PE11.6/4, PE13.1/10,
PE9.2/4
Benhamou Y. PE13.1/13
Beniken D. PE13.2/7
Beniowski M. PE3.1/1, PS2/3
Bennai Y. PE7.3/2
Bentata M. PS5/3, PS5/4
Bento D.P. PE20.7/1
Berenguer J. PS2/7
Berg C. PE13.5/1
Berg T. PE3.3/3
Berger D. BPD2/1
Berger F. PE4.1/2, PE7.4/3,
PE9.7/1, PE9.7/3
Berger M. PS3/4
Bergin C. PE18.5/1
Bergmann S. PE2.4/3
Bernal E. PS2/7
Bernardino J.I. BPD2/3
Bernasconi E. PE7.4/1, PS12/5,
PS5/2, LBPS5/7
Bernstein B. PE10.1/1, PE3.3/1,
PE7.3/3
Bernstein B.M. PE7.5/3
Berthe H. BPD2/5
Bevilacqua M. PE9.7/4
Bezemer D. LS2/1
Bianchi A. PE1.2/8
Bickel M. PE13.5/1, PE9.2/1
Bieniek B. PE3.3/3, PE7.9/19,
PE7.9/20, PS12/6
Biesiada G. PE12.2/1
Bignami F. LBPE13.5/2
Bigoloni A. PE9.2/5, PS6/3
Billaud E. PE7.9/1, PE7.9/15
Billy C. BPD2/5
Bilzer M. PE13.2/3
Bini T. PE9.10/1
Birabwa E. PE19.2/2
Biron C. PS11/1
Bisi L. PE10.1/3, PE13.2/5,
PE13.2/6
Bissagnene E. PE9.1/1
BITE Study Group BPD2/4
Bittar R. PE9.8/2
Blaizeau M.-J. LBPE9.7/8
Blanc C. PE7.2/5, PE9.8/2
Blanch J. BPD2/6
Blanco F. PE7.9/12
Blanco J.R. PE18.4/6
Blazquez D. PS9/3
Bloch M. PE7.9/11
Bobkova M. PE1.1/1, PE3.5/1,
PE4.4/1
Boccara F. PS11/2
Bodem J. PE3.1/9
Boesecke C. PE2.7/1, PE6.12/1,
PE7.9/11
Boffito M. PE4.3/2
Bogner J. PE4.1/2, PS3/4
Bogner J.R. PS12/6, PS3/3
Bohlius J. BPD1/1
Boix V. PE9.2/2
Bolao F. PE20.3/2
Bollmann B. PE2.2/1
Bombana E. LBPE4.3/5
Bonfanti P. PE9.7/4, PS11/4
Bonmarchand M. PE14.8/2
Bonnard P. PE7.2/3
Bonnet B. PE7.9/1, PE7.9/17
Bonnet F. LBPE9.7/8
Bonora S. PE4.1/7
Booth C. PE1.2/6
Booth C.L. PE3.1/6
Borchi B. PE7.4/6
Borghero G. PE12.3/1
Borghi V. PE13.2/5,
PE13.2/6
Borissov K. PE6.1/1, PS3/6
Bortolozzi R. PS4/3
Boschi A. PE11.2/2
Bossolasco S. PS6/3
Bottecchia M. PS2/7
Bouchaud O. PE9.1/1
Boucher C.A.B. LBPE1.2/9
Boue F. PE4.1/2
Boue F. PS6/4
Bouldouyre M.-A. PE18.5/4
Boulet T. PE7.2/2
Boumis E. PE19.3/1, PE3.4/10
Bouteloup V. LBPS6/7
Boven K. PE4.3/3, PE7.1/2
Bowden S. PS2/1
Bower M. PE13.1/1
Boyer L. PE4.1/5
Bracciale L. PE10.1/7, PE10.1/8,
PE3.4/9, PE4.3/4,
PE9.11/1
Brackenridge S. PE2.4/2
Brainard D. PE4.1/1
Brandolini M. PE7.5/2
Bratholm C. LBPE19.10/2
Braun J. PE1.4/3
Bray D. PE8.3/1
Bregigeon S. PS11/1
Bremer V. BPD1/4, PE18.5/3
Brengelmann S. PE13.4/5
Brenner B.G. PE3.4/4
Breton G. PE10.4/7
Brockmeyer N. PE4.1/2
Brockmeyer N.H. PE10.4/5, PE18.4/5,
PS12/6, PS8/7
Broco S. PE12.5/2
Brodt H.-R. PE9.2/1
Brogan A. PE19.5/3
Bronke C. PE3.5/2
Brown K. PE7.1/1
Brunet-Francois C. PE14.2/1, PE7.9/1,
PS11/1
Brunner A. PE7.9/22
Brun-Vezinet F. PE1.4/1
Brun-Vezinet F. PE3.2/2, PE7.3/2,
PS10/5, PS12/3,
LBPE1.2/9
Bruun J.N. LBPE19.10/2
Bruyand M. PS8/5
Bucciardini R. PE7.4/11
Bucher H. PE7.4/1
Buckton A.J. PE3.4/5
Buelens A. PE4.3/3, PE7.1/2
Buhk T. PE10.4/5
Bui-Phan E. PE14.2/1
Buppi P. PE4.6/1
Burger D. PE15.2/1
Burke M. PE10.1/2, PE9.7/6
Burty C. PE4.1/5
Busmann A. PS10/4
Byakika-Kibwika P. PE19.9/1
Bykova L. PE19.7/2
CCabie A. PE7.9/18, PE9.1/3
Caby F. PE13.2/7, PE7.2/5,
PE7.2/6, PE9.8/2
Cadranel J. PS6/4
Caggese L. PE10.4/6
Cahn P. BPD2/4, PS4/3, PS4/4
Cairns V. PE7.3/1, PS10/3
Calabrese P. PE9.5/3
Calabuig E. PE20.4/3
Calcagno A. PE4.1/7
Calia G.M. PE12.3/1
Callegaro A. PE17.2/2, PE3.4/10,
LBPE4.3/5
Calmy A. PS10/5, PS12/5
Calvez V. PE14.8/2, PE4.1/3,
PE4.2/1, PE7.2/5,
PE7.2/6, PE7.3/2,
PS12/2, PS12/3,
PS12/4
Calza L. PE11.2/1, PE18.4/2,
PE19.1/2
Calzi A. PE13.2/8
Camacho A. PE13.2/1
Camacho R. PE3.1/8, PE7.4/9
Camacho R.J. PE1.1/2
Camanni G. PE9.7/5
Campaniello M. PE9.7/4
Campbell L. PE9.5/5
Campbell L.J. PS5/6
Campins A. PE18.1/3
Canadas M.P. PS3/5
Canestri A. PE10.4/7, PE13.2/7,
PE9.8/2
Canoves L. PE13.2/2, PE9.1/2
Cao F. PE9.1/1
Capeau J. LBPS6/7
Capitant C. PE3.2/2
Capobianchi M.R. PE10.1/11, PE17.1/2,
PE9.5/8, PS2/5
Capobianco G. PE12.3/1
Caprani A.R. PE5.10/1
Caramma I. PE9.6/1
Carducci A. PE13.4/4
Carenzi L. PE9.7/4
Carganico A. PE10.4/5, PE3.3/3
Carlebach A. PE7.4/3, PE9.2/1,
PE9.7/1
Carletti F. PS11/5
Carli F. BPD2/2, PE9.10/2,
PE9.5/10, PS11/3
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 223
Carmagnat M. PE13.4/3
Carmena J. PE13.2/2, PS5/1
Carnevale G. PE3.4/10
Carosi G. PE10.4/2
Carr A. PS10/2
Carulla M. PE7.9/16, PE9.5/4
Carulli L. PS11/3
Casado J.L. PE7.4/10, PE7.4/8,
PE7.9/2, PE7.9/8,
PE9.6/5, PS3/7
Case N. BPD1/9
Caseiro M. PE7.2/8
Casiro A.D. PS4/3
Casoli C. LBPE13.5/2
Cassetti I. PS4/3
Castagna A. LS2/2, PE10.4/6,
PE9.2/5, PS6/3
Castaigne C. PE11.1/4, PE12.1/1
Castano M. PE9.2/3, PE9.8/1,
PS4/7
Castella E. PS3/5
Castelnuovo B. PE10.2/1
CASTLE Study Group PE7.3/8, LBPS11/6
Castorina S. PE19.3/1
Castrec E. PE3.1/7
Castro V. PE18.5/2
Cattani P. PS3/1
Cattaneo D. LBPE4.3/5
Cattelan A. PE7.5/2
Cattelan A.M. PE9.9/4
Cauda R. PE10.1/8, PE12.2/2,
PE4.3/4, PE7.9/21,
PE9.11/1, PE9.5/8,
PS11/5
Cavaco-Silva J. PE1.1/2
Cavassini M. PE18.5/1, PE20.1/1,
PE7.4/1, PS12/5,
PS5/2, LBPS5/7
Cayla J. PS8/5
Cazanave C. LBPE9.7/8
Ceausu E. PS2/6
Ceberio L. PE18.4/7
Ceccarelli G. PE13.4/4
Ceccherini-Silberstein F. PE18.4/4, PE3.4/10
Cecchetto M.G. PE9.9/4
Cervantes M. BPD2/6, PE13.1/12
Chadwick D. PE13.1/9
Chaiwarith R. PS8/1
Chaix M.-L. PE1.4/1, PS12/4
Chan S.-S. BPD2/7
Chang J. PS2/1
Chang S.-C. PE13.3/2, PE13.4/1
Chang S.-Y. PE13.3/2, PE13.4/1
Chang Y.-C. PE13.4/1
Chantratita W. PE3.5/7
Chapman D. PE3.4/8
Charles M. PE19.1/3
Charpentier C. PS12/3, PS12/4
Charreau I. PE7.2/2
Chave J.-P. PS12/5
Chazallon C. PE3.2/2
Chene G. PE3.1/7, LBPS6/7,
PS10/5
Cheneau C. PE4.1/5
Chentsova N. PS8/5, PS8/6
Cheserem E. PE9.5/5, PS5/6
Chevret S. PE13.4/3
Chi B. PE19.7/4
Chiavaroli R. PE9.5/2, PE9.5/3
Chiesi A. PS3/3
Chighine A.L. PE12.3/1
Childs K. PE9.5/5
Chinello P. PE19.3/1
Chini M. PE3.1/5
Chintu N. PE19.7/4
Chiotan C. PE11.6/4
Chirouze C. PE4.1/5
Chkhartishvili N. PE17.2/1
Chopra A. PE3.5/2
Chotiprasitsakul D. PE13.1/3
Christ H. PE13.4/5
Christofides T. PE3.2/3
Chrysos G. PE3.1/5, PE7.3/4
Chrystie I. PE20.6/1, PE3.5/3,
PE3.5/8
Chueca N. PE1.2/1, PE1.2/7
Ciardi A. PE13.4/4
Cicalini S. PE19.3/1
Ciccozzi M. PE17.2/2
Cingolani A. PE10.1/7, PE10.1/8,
PE12.2/2
Cinque P. PS6/3
Ciprian D. LBPE1.2/10
Clark A. PE4.1/6, PE4.3/1,
PE4.3/3
Claudine D. PE13.1/13
Clavel-Osorio C. PE13.2/7
Clementi E. LBPE4.3/5
Clerici M. BPD2/4, PE8.3/1
Clinical Epidemiology
Group of the French
Hospital Database on
HIV PS11/2
ClinSurv Study Group PE7.4/7
Clotet B. BPD2/6, LBPE1.2/9,
PE13.3/1, PE3.1/1,
PE3.1/2, PE7.3/9,
PE7.4/9, PS10/3,
PS12/1, PS3/5
Clumeck N. PE7.3/6, PE7.3/9,
PS3/2
Coakley E. PE1.2/2
Coate B. PE10.1/12,
PE4.1/8
Codoner F.M. PE3.1/8
Coelho R. PE18.4/8
Coenen M. PS2/8
Cofan F. PE18.1/4
Cohen C. PS4/2
Cohen D. PE3.3/1
Cohen Y. PE10.1/2
Cohorte de Adolescentes
VIH de Madrid PS9/3
Coinu G. PE12.3/1
Colafigli M. PE10.1/8, PE3.4/9,
PE4.3/4, PE9.11/1,
PE9.5/8, PS11/5
Colberg K. PE2.6/3
Colbers A. PE15.2/1
Colebunders R. PS6/6
Colella E. PE1.2/8
Coletto S. PS9/6
Collaboration of
Observational HIV
Epidemiological Research
Europe (COHERE)/
Opportunistic Infections
Working Group PS8/3, PS8/4
Collado A. PE13.2/1
Collin G. PE1.4/1, PE3.2/2
Collomb D. PE10.4/3
Colson A. PS4/2
Combes F. PE4.2/1
Comi L. PE9.10/1
Comisar W. PE4.1/1
Competence Network
for HIV/AIDS PS8/7, PE10.4/5,
PE18.4/5
Compston J. PE9.10/2
Cooper D. BPD1/6
Cooper D.A. PE2.7/1, PE6.12/1,
PE7.9/11, PS10/2
Cooper C.L. LBPE18.5/8
COPA PE8.3/1
Corbasi P. PS3/5
Corbett C.J. PE19.5/4
Cordes C. PE3.3/3
Cordes J. PE13.2/4
Cordoner F.M. PE1.2/7
Cordova E. PE11.2/2
CoRIs PS2/7
CoRIS-MD Cohort PE18.4/6
Cornelis L. PE4.3/3
Corpolongo A. PE17.1/2
Corrah T. PE2.4/2
Corral I. PS3/7
Correa I. PE1.2/1
Cosin J. PE9.2/3, PS4/7
Costagliola D. BPD2/8, PS11/2,
PS12/2, PS5/3,
PS5/4, PS6/4
Costela C. PE1.2/1
Costelloe S. PE3.5/8
Costinescu C. PE9.2/4
Cottalorda J. PS12/3, PS12/4
Cotte L. PS11/2
Coussem*nt W. PE7.1/4
Cozzi V. LBPE4.3/5
Cozzi-Lepri A. LS2/2, PE3.1/1,
PE3.1/2, PE9.5/8,
PS11/5
Crauwels H. PE4.3/3, PE7.1/2
Creah R. PE9.6/6
Crespo M. PE7.3/10
Croce F. PE9.6/1
Cuadrado J.M. PE13.2/2, PE20.4/3
Cucurull J. PE13.1/12
Cuko G. PE9.10/1
Curran A. PE3.5/6, PE7.3/10
Currier J. PE10.1/12
Curto J. PE9.3/4
Cuyckens F. PE7.1/3
Cuzin L. PE7.9/18, PE9.1/3
Czepiel J. PE12.2/1
Dda Silva B. PE3.3/1
Dabis F. LBPE9.7/8
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
224 Author Index
Dailly E. PE7.9/17
Dalmau D. BPD2/6, PE1.2/7,
PE13.1/12
Damond F. PE1.4/1, PE1.4/2
Dang N. PS12/1
Danta M. PE7.9/11
Darasteanu I. PS5/3, PS5/4
d’Arminio Monforte A. LS2/2, PE10.4/6,
PE3.1/2, PE9.10/1,
PE9.5/8,PS11/5,PS2/2
Darwich L. PS3/5
Dauby N. PS3/2
Dauchy F.-A. LBPE9.7/8
Davidyan A. PE7.9/6
D’Avino A. PS11/5
Davis G. PE4.1/7
D’Avolio A. PE4.1/7
Dawood N. PE3.5/3
De Carli G. BPD1/5, PE17.1/2
De Castro N. PE1.4/3, PE13.4/3,
PE18.5/4, PE7.2/2
De Curtis A. PE9.5/8, PS11/5
de Gaetano Donati K. PE9.5/8, PS11/5
De Gascun C. PS9/1
De Jesus E. LBPS10/6
De Jose M.I. PS9/3
De Jose M.L. PS9/5
De Kanter K. PE15.2/1
De La Faille R. LBPE9.7/8
de la Iglesia A. PE11.6/3
De La Rosa G. PE4.1/8, PE7.4/5
De Lazzari E. PS10/2
De Longis P. PE18.4/4
de los Santos-Gil I. PE13.2/1
De Luca A. LBPE1.2/9, PE10.1/7,
PE10.1/8, PE10.4/6,
PE12.2/2, PE3.1/8,
PE3.4/9, PE4.3/4,
PE7.4/9, PE9.11/1,
PE9.5/8, PS11/5,
PS3/1
de Matıas M. PE14.6/1
De Matteis G. PE10.1/7, PS9/6
De Mendoza C. PE7.9/12
De Miguel Prieto J. PE11.6/2
de Otero J. PE7.9/9
De Rosa A. PE6.7/1
de Rossi L. PE7.3/11, PS10/3
de Ruiter A. PE3.5/8
De Salvador F. PE7.9/18
De Schaepdrijver L. PE7.1/4
De Smedt G. PE4.3/1
De Socio G.V. PS11/4
de Sousa J.D. PE1.1/2
de Truchis P. BPD2/5, PE3.1/4,
PE7.5/5
De Wit S. PE11.1/4, PE12.1/1,
PE7.3/6, PS2/2,
PS3/2, PS6/1
de Wolf F. LS2/1, PE3.5/5
Deeks S. PE2.4/2
Degen O. PE13.4/2, PE4.1/2
DeGrosky M. PE7.3/8, LBPS11/6
Dehovitz J.A. PE17.2/1
Deig E. PE7.3/10, PE7.9/16,
PE9.2/3, PS4/7
DeJesus E. PE7.2/1, PE7.2/4
deJesus E. PS4/2
del Amo J. PE18.4/6
del Arco A. PE7.9/9, PE9.8/1
del Pozo M.D.M. PE2.1/1, PE2.6/1
del Pozo-Balado M.D.M. PE13.1/8
del Rio L. PE9.3/4
Delaitsch L. PE7.4/5
Delassus J.-L. PE7.5/5
Delaugerre C. PE1.4/3, PE18.5/4,
PE3.1/4, PS12/4
Delegido A. PE13.1/12, PE7.9/16,
PE9.5/4
Delforge M. PE7.3/6, PS3/2
Delgado M. PE13.2/1
Delgado R. PS4/6
Dellamonica P. PE9.1/3
Delsol E. PE7.4/10, PE7.4/8
Deltoro M.G. PE9.1/2
Demasi R. PE7.3/4
Denoeud L. PE9.1/1
Desai M. PE12.1/2
Desbois D. PS12/3
Descamps D. PE1.4/1, PE3.2/2,
PE4.2/1, PE7.3/2,
PE7.5/5, PS12/3,
PS12/4
Desmidt M. PE7.1/4
Dessole S. PE12.3/1
Detsika M.G. PE3.1/5
d’Ettorre G. PE13.4/4
D’Ettorre G. PE4.3/4
Dew T. PS5/6
Di Biagio A. PE10.1/4, PE13.2/8
Di Giambenedetto S. PE10.1/7, PE10.1/8,
PE3.1/8, PE3.4/9,
PE4.3/4, PE7.9/21,
PE9.11/1, PS3/1
Di Perri G. PE4.1/7, PE7.3/11,
PE7.9/21
Diaz R. BPD2/4
Diaz R.S. PE10.1/13, PE7.2/8
Dickinson L. PE4.3/2
Diede B. PE3.2/4
Dietz B. PE10.4/3
Dimitrijevic V. PE19.8/1
Ding E. LBPE18.5/8
Djessou P. PE9.1/1
Dlugay V. PE10.4/5
D’Offizzi G. PE19.3/1
Dom P. PE7.1/4
Domingo P. BPD2/6, PE18.1/6,
PE3.5/6, PE7.3/10,
PE7.9/2, PE7.9/9,
PE9.2/3, PE9.3/4,
PS4/7, PS8/6
Dominguez S. PE13.1/13, PE14.8/2,
PE9.1/3
Donatz V.M. PE19.5/4
Dong T. PE2.4/2
Dong W. PE3.4/8
D’Onghia S. PS3/1
Dore G. PS2/1
Doroana M. PE18.5/5
Doroshyenko O. PE4.1/9
Dorrie J. PE2.4/3
Draganescu M. PE13.1/10
Dressler S. LBPE1.2/9
Drimis S. PE3.1/5
Driz R. LBPE7.2/9
Drobacheff C. PE4.1/5
Dronda F. PE7.4/10, PE7.4/8,
PE7.9/8, PE9.6/5,
PS3/7, PS4/6
Druyts E. LBPE18.5/8
Duiculescu D. PE3.1/1, PE3.4/5,
PE7.3/11, PS2/6
Dundarova D. PE6.1/1
Dunkle L. BPD1/9, PE7.2/8
Dunn D. PE3.1/8
Dupke S. PE3.3/3
Dupon M. LBPE9.7/8
Dupont C. BPD2/5
Dusza M. PE18.1/7
Duvivier C. PE10.4/7, PE7.5/5,
PE7.9/18, PE9.1/3,
PS12/2
Dvali N. PE17.2/1
EEASIER ANRS 138 Study
Group PE7.2/2
Eberhard J. PE2.2/1
Ebrahimi R. BPD2/7
Egan D. PS12/6
Eholie S. PE9.1/1
EHR, Virolab, EuResist
and BREACH Projects PE7.4/9
Eismann K. PE2.4/3
Elbirt D. PE10.1/2
Elbirt D.G. PE9.7/6
Elia P. PE17.1/2
Elzi L. PS12/5, PS5/2,
LBPS5/7
Emery S. PE2.7/1, PE6.12/1,
PE7.9/11, PS10/2
Emmanuel M. PE7.7/1
Emmelkamp J. PE13.3/1
Ename-Mkoumazok B. PS5/3
Ene L. PE3.4/5, PS2/6
Erhan R. PS2/6
Escoin C. PE9.2/2
Escolano C. LBPE1.2/10
Escrich C. PE13.1/12
Esposito R. PE13.2/5, PE13.2/6,
PE7.9/21, PE9.10/2
Esser S. BPD1/2, PE1.2/4,
PE1.2/5, PE18.4/5,
PE18.5/1, PS12/6
Essig A. PE9.9/2
Esteban H. PE7.9/2
Estrada V. PE9.2/3, PS4/7
Euphrasie F. PE7.2/2
Europe (COHERE) PS8/3, PS8/4
European Consensus
Group on clinical
management of tropism
testing LBPE1.2/9
EuroSIDA Investigators PE18.1/4
EuroSIDA Study Group PE3.1/1,PS3/3,PS8/6,
PE3.1/2,PS2/2,PS2/3,
PS6/6, PS6/1
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 225
FFabbiani M. PE10.1/7, PE10.1/8,
PE3.4/9, PE4.3/4,
PE9.11/1
Fajardo J.M. PE11.6/3
Falasca K. PE9.5/9
Falco V. PE7.3/10
Faller J.-P. PE4.1/5
Falutz J. BPD2/1, PE2.6/4
Fanti I. LS2/2, PE10.1/8,
PE12.2/2, PE3.1/8,
PE9.11/1
Farajallah A. PE7.3/8, LBPS11/6
Faraone A. PE9.5/2, PE9.5/3
Faria N.R. PE1.1/2
Farina S. PS3/1
Fatkenheuer G. BPD1/2, PE1.2/4,
PE1.2/5, PE13.4/5,
PE4.1/9, PE6.5/1,
PE7.3/7, PS12/6,
PS3/3, PS3/4, PS12/7
Fernandes J. PE18.5/5
Fernandez Garcia E. LBPS10/6
Fernandez M. PE14.9/2
Ferraioli G. PE9.3/2
Ferramosca S. PE1.2/8
Ferrando R. PE13.2/2
Ferrando S. PE2.6/1
Ferrando-Martınez S. BPD2/9, PE2.6/2
Ferrandu G. PE12.3/1
Ferre V. PS12/3
Ferreira D. PE18.4/8
Ferreira P.R.A. PE10.1/13
Ferrer E. BPD2/6, PE9.3/4
Ferris R. PE7.1/1
Feuillebois N. PE7.9/15, PE7.9/17
Feys C. PE4.1/6
FHDH-ANRS CO4
Epidemiology Group PS6/4
Filice C. PE9.3/2
Fillekes Q. PE15.2/1
Filmann N. PE9.7/3
Finkielsztejn L. PE9.1/3
Finlayson R. PE7.9/11
Fiogbe A.A. PE19.7/1
Fiore A. PE13.4/4
Firlag-Burkacka E. PE9.6/3
Fisher M. LBPS10/6, PS3/3
Fisicaro P. LBPE13.5/2
Flachskampf F. PE9.5/7
Flamm J. PE7.3/4
Flandre P. PE14.8/2, PE7.3/2,
PS12/3, PS12/4
Fleury H. PS12/3
Flexor G. LBPS6/7, BPD2/5
Flisiak R. PS2/2
Flores J. PE13.2/2
Foltzer A. PE4.1/5
Fontanet A. PE18.1/6
Forbici F. PE18.4/4, PE3.4/10
Force G. BPD2/5
Force L. BPD2/6
Forssmann W.G. PS10/4
Foster S. PE7.1/1
Fox Z. PE20.6/1, PE3.1/2
Frago I. PE18.4/7
Frago Marquinez I. PE10.1/6
Fraile B. PE14.6/1
Franceschini E. PE13.2/5, PE13.2/6
Francisci D. PE3.4/10, PE3.4/7,
PE9.7/5
Frank D. PE4.1/9
Frankfurt Cohort
Study Group PE9.2/1
Fransen K. PE7.9/13
Fraser C. LS2/1
Fredrick L. PE10.1/1, PE7.3/3
Fredrick L.M. PE7.5/3
Freiwald M. PE18.4/5
Fuentes Ferrer M. PE9.2/3
Fuhr U. PE4.1/9
Fujiwara T. PE7.1/1, PE7.2/4
Fumagalli L. PS6/3
Furrer H. PE3.5/2, PS12/5,
PS5/2, LBPS5/7,
PS8/3, PS8/5
Fust G. PE8.1/1
Fuster M. PE9.2/3
f*ck C. PE7.4/1, PS12/5
f*ck C.A. PE18.1/4
GGabiano C. PS9/4
Gabrielli E. PE9.3/2
Galera C.E. PE1.2/7
Galiano A. PE18.5/2
Galindo M. PS4/7
Galindo M.J. PE9.2/3
Gallego M. PE18.4/3, PE9.8/1
Galli L. PE9.2/5, PS6/3
Galli M. PE1.2/8, LBPE13.5/2,
PE7.9/21, PE9.3/2,
PE9.6/1
Gallien S. PE1.4/3
Gallotta G. PE9.2/5
Galvez C. PE9.8/1
Ganon A. PE1.4/1
Ganten T. PE13.5/1
Garb J. PS4/2
Garcia A. PE13.1/9
Garcıa Alcalde M.L. PE9.2/3
Garcıa F. PE1.2/1, LBPE1.2/9
Garcia F. PE1.2/7
Garcia I. BPD2/6
Garcia J. PS3/7
Garcıa M. PE18.5/6, PS9/3
Garcıa Mellado I. PS9/5
Garcıa P. PE7.9/16
Garcia Vidal M. PE11.6/2
Garcia-Alcalde M.L. PS4/7
Garcıa-Cuyas F. PS3/5
Garcia-Diaz A. PE3.1/6
Garcıa-Guerrero J. PE9.5/1
Gargalianos P. PE3.1/5, PE7.9/23
Garlicki A. PE12.2/1
Garnett G. LS2/1
Garrido M. PE9.2/3, PS4/7
Garro S. PE11.2/2
Garssen J. BPD2/4, PE8.3/1
Garvey E. PE7.1/1
Garvey L. PS6/5
Gaspar G. PE3.5/6
Gatell J.M. PE18.1/4, PE9.3/4,
PS10/2
Gathe, Jr. J. PS4/5
Gaubert M. PE20.4/3
Gaudieri S. PE3.5/2
Gaultier I.A. PE7.5/3
Gavazova R. PE6.1/1, PS3/6
Gaytan-Martinez J.E. PE13.1/11
Gazzard B. BPD2/4, PE4.3/2,
PS6/1
Gazzola L. PE9.10/1
Gedela K. PE4.3/2
Geijo P. PE9.2/3, PS4/7
Geine M. PE13.1/6
Geleziunas R. LBPE1.4/4
Gelgor L. PE7.9/11
Gellermann H.J. PE7.3/11, PS10/3
Gendron A. PE7.3/2
Genebat M. BPD2/9, PE2.6/2
Genova-Kalou P. PE6.1/1
Gerbaud L. PE5.10/1
Geretti A.M. PE1.2/6, LBPE1.2/9,
PE10.4/1, PE13.1/9,
PE20.6/1, PE3.1/6
German Competence
Network for HIV/AIDS PE9.5/7, PS12/6
German Hepatitis Group PS2/4
Gervasoni C. PE7.9/21, PE9.3/2,
PE9.7/4
GESIDA 5808 Study Group PE7.9/2,
PE7.9/9
Ghinelli F. PS11/5
Ghirga P. PS2/5
Ghisetti V. PE3.1/8
Ghosn J. PS12/2
Giacomet V. PS9/4, PS9/6
Giancola M.L. PE10.1/10,
PE10.1/11,
PE19.3/1
Gianotti N. PE9.2/5, PS6/3
Giaquinto C. PE3.4/5
Gibbons S. PS12/5
Gielen J. PE13.4/5
Giganti M. PE19.7/4
Gil L. PE18.1/3
Gilquin J. PS11/2
Gilsdorf A. BPD1/4, PE18.5/3
Giner L. PE9.2/2
Girard P.-M. PE3.1/7, PE3.2/2,
PE7.2/6, PE7.3/5,
PE9.1/1, PS3/3
Girardi E. LS2/2, PE10.4/6,
PE17.1/2, PE19.3/1,
PS2/5, PS8/5
Giri S.R. PE19.1/3
Glaubitz J. PE1.4/1
Gnesivo C. PS2/5
Gobir I.B. PE11.1/2
Gochitashvili N. PE17.2/1
Goetzenich A. PE12.5/1
Goey H. PE13.2/3
Goglio A. PE17.2/2
Gohlke-Micknis S. LBBPD1/3
Goldbach J. PE7.3/1
Golds K. PE18.1/1
Golochvastova E. PE13.1/5
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
226 Author Index
Golz J. PE10.4/5, PE13.2/3,
PE13.2/4, PE3.3/3,
PS2/4
Gomez-Sirvent J.L. PE18.4/6, PE18.5/1
Goncalves M.F. PE1.1/2
Gonzalez J. BPD2/3
Gonzalez M. PE14.6/1, PE14.9/2
Gonzalez Mena A. BPD1/8
Gonzalez Tome M.I. PE14.6/1, PE14.9/2,
PS9/3, PS9/5
Gonzalez-Garcıa J. PE7.9/2
Gonzalez-Lahoz J. PE7.9/12
Gonzalez-Serna A. BPD2/9
Gonzalez-Serrano M. PE18.1/2, PE18.4/3
Gonzalo X. PE11.2/2
Goonetilleke N. PE2.4/2
Gorgolas M. PS4/6
Gori A. BPD2/4, PE10.1/3,
PE8.3/1, PS11/5
Gori C. PE18.4/4
Gorka A. PE18.4/7
Goubau P. PE1.1/2
Gradstein S. PE10.1/2, PE9.7/6
GRACE Study Group PE10.1/12
Granado L.I. PS9/3
Grant A. PE7.9/10
Graves-Abe K. PE19.1/3
Grbic M. PE19.8/1, PE19.9/2
Grbic R. PE19.8/1
Greaves W. BPD1/9, PE7.2/8
Greder-Belan A. BPD2/5
Gregori J. PS5/1
Greib C. LBPE9.7/8
Grigoryan S. PE7.9/4, PE7.9/5,
PE7.9/6
Grima P. PE7.9/21, PE9.5/2,
PE9.5/3
Grimm K. PE10.1/9
Grinspoon S. BPD2/1
Grinsztejn B. PE7.3/5
Grisetti S. PS2/5
Group for the Study of
Viral Hepatitis (HEPAVIR)
of SAEI PE13.2/1
Groupe d’Epidemiologie
Clinique du SIDA en
Aquitaine LBPE9.7/8
Gruner B. PE9.9/2, PE9.9/3
Guaraldi G. BPD2/2, PE9.10/2,
PE9.5/10, PS11/3
Gudbrandottir I. PE9.3/5
Guelar A. PS5/1
Guelar Grimberg A. BPD1/8
Guerri R. BPD1/8
Guffanti M. PS6/3
Guido M. PE9.5/2, PE9.5/3
Guiguet M. PS6/4
Guillot V. PE1.2/1, PE1.2/7
Guimaraes M. PE18.5/2
Guisasola Ron L. PE10.1/6
Guiyedi V. LBPS6/7
Gulizia R. PE9.3/2
Gundersen S.G. LBPE19.10/2
Gunthard H. PE7.4/1
Gunthard H.F. PE3.5/2
Gurbindo D. PS9/3, PS9/5
Gute P. PE7.4/3, PE9.2/1,
PE9.7/1
Gutierrez C. PE7.4/10, PE7.4/8
Gutierrez C. PE7.9/8
Gutierrez F. LBPE1.2/10
Gutierrez F. PE18.4/6
Gutierrez M. PE7.3/10
Gutierrez M.M. PE18.1/6
HHa B. PE7.2/1
Haastert B. PE18.4/5
Habel A. PS4/2
Hamouda O. LBBPD1/3, BPD1/4,
BPD1/3, E18.5/3,
PE7.4/7
Hamzah L. PE9.5/5, PS5/6
Hanlon M. PE3.5/8
Harding R. PE10.4/4
Hardy D. LBPS10/6
Harrer E. PE2.4/3
Harrer E.G. PE9.5/7
Harrer T. PE18.4/5, PE2.4/3,
PE9.5/7, PS12/6
Harrigan P.R. PE3.3/2, PE3.4/8
Harris R. PE13.1/2
Harter G. PE9.9/2, PE9.9/3
Hartjen P. PE2.6/3, PE6.5/1
Hartmann P. PE6.5/1, PS12/7
Harvey C. PE7.2/7
Haskelberg H. PE2.7/1
Hatzakis A. PE3.1/5, PE7.9/23
Hauber J. PE2.6/3
Haussinger D. PE3.5/4
Hawkins T. PE7.2/1, PE7.2/4
Hazen R. PE7.1/1
Hechler D. PS8/2
Heera J. PE3.4/8, PS12/1
Hegener P. PE9.7/1, PE9.7/3
Heger E. PE1.2/4
Hein W. PE4.1/9
Hendra H. PS12/6
Hendrickx A. PE7.3/7
Hendry B. PS5/6
Henke J. PE13.2/3, PE9.7/1,
PE9.7/3
Hensel M. PE12.5/1
Hentrich M. BPD1/2, PS3/4
Hermes A.E. PE7.5/3
Hernandez Novoa B. PE3.5/6
Hernandez-Quero J. PE1.2/1,
PE1.2/7
Hernando K. BPD2/6
Herrero A. PE9.5/1
Herrmann E. PE9.7/3
Herson S. LBPS6/7
Hidalgo C. PE1.2/7
Hildebrand M. PE7.3/6
Hill A. PE19.5/2, PE19.5/3,
PE19.5/5, PE3.4/1,
PS4/1
Hill A.M. PE7.5/4
Hillenbrand H. PE3.3/3
Hillis S. PS9/2
Hinterberger A. PE7.4/2
Hintsche B. PE3.3/3
Hirschel B. PE7.4/1, PS5/2,
LBPS5/7
Hita C. PE1.2/1
Hitzenbichler F. PE13.5/1
HIV/TB Study Group PS8/5
Hjelmgren J. PE19.5/1
HLA-Epi Teams PE18.5/1
Hluhanich R. LBPE1.4/4
Hodges-Mameletzis I. PE1.1/2
Hoen B. PE4.1/5
Hoetelmans R. PE4.3/3
Hoetelmans R.M. PE4.3/1
Hoffmann C. BPD1/2, BPD1/9,
PE13.2/3, PS3/4
Hofmann C. PE13.2/9, PE2.4/3
Hogg R.S. LBPE18.5/8
Hoitsma A. PE15.2/1
Holberg-Petersen M. LBPE19.10/2
Hollingsworth D. LS2/1
Holm S. PE7.9/19,
PE7.9/20
Holmes M.V. PE13.1/2
Hong H.S. PE2.2/1
Horban A. PE7.3/11, PE9.6/3,
PS8/6
Hosey T. PE7.3/8
Houssaıni A. PE14.8/2
Hower M. PE7.9/19, PE7.9/20
Hristea A. PE11.6/4, PE9.2/4
Hsieh C.-Y. PE13.4/1
Huang W. PE1.2/2
Huber M. PE11.5/2, PE7.9/22,
PE9.5/6
Humpheries A. PS10/2
Hung C.-C. PE13.3/2, PE13.4/1
Husstedt I.W. PE6.9/1
Hylomenos G. PE3.1/5
IIacoviello L. PE9.5/8, PS11/5
Ibrahim F. PE9.5/5
Icona Foundation
Study Group LS2/2, PE10.4/6,
PE9.5/8, PS11/5
IDI Cohort Study Team PE10.2/1
Ignatowska A. PE9.6/3
Imaz A. PE7.3/10
Indinnimeo M. PE13.4/4
Ingiliz P. PE13.1/13
Ion D. PE9.2/4
Ionescu C. PS2/6
Iosipenco M. PE11.6/4
Ippolito G. BPD1/5, PE10.4/6,
PE19.3/1, PS2/5
Iribarren J.A. PE18.4/6
ISS-NIA Group PE7.4/11
Italian Registry of
Antiretroviral
Post-Exposure
Prophylaxis BPD1/5
Ivanov D. PE6.1/1
Ivars M. PE20.4/3
Ive P. PE7.3/4
Iwamoto M. PE4.1/1
Izopet J. PS12/3
Izurieta P. PE4.1/6
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 227
JJackel M. PE2.2/1
Jackson A. PE4.3/2, LBPE9.2/8,
LBPS10/6
Jacquemyn B. PE3.3/4
Jacquet J.-M. PE9.9/1
Jaeger H. PE7.9/19, PE7.9/20
Jager H. PE12.5/1, PS12/6
Jallow S. PE1.1/2
James I. PE3.5/2
Jamieson D.J. PS9/2
Janeiro N. PE18.5/5
Jansen K. BPD1/4, PE10.4/5,
PE18.4/5, PE18.5/3
Janssen K. PE4.3/1
Jarrin I. PE13.1/4, PE18.4/6
Jayaweera D.T. LBPS10/6
Jensen B. BPD1/2, PE1.2/5
Jensen B.-E.O. PE3.5/4
Jensen J. PS4/2
Jensen M. PE3.4/8
Jessen A. PS8/2
Jessen H. PS8/2
Jetter A. PE4.1/9
Jevtovic D. PS2/3
Ji D.-D. PE13.4/1
Jimenez Exposito M.J. PE3.5/6
Jimenez M. PE11.6/3
Jimenez S. PS9/3
Johannessen A. LBPE19.10/2
Johansson H. PE9.10/2
John M. PE3.5/2
Johns B. PE7.1/1
Johnson M. PE10.4/4, PE3.1/6,
PE7.3/8
Jou T. PS3/5
Jousset N. PE3.1/4
Jovelin T. PE7.9/1, PE7.9/17,
PS11/1
Jover F. PE20.4/3
Juarros J.L. PS4/6
Juday T. PE10.1/9
Judd A. PE3.4/5
Jung N. PS12/7
Junod P. PS4/3
Jurke A. PE16.6/1
KKabeya K. PE7.3/6
Kaiser R. PE1.2/4, PE1.2/5,
LBPE1.2/9, PE3.1/8,
PE3.2/4, PE3.5/4,
PE7.4/9
Kakuda T.N. PE4.1/6, PE4.3/1
Kalanzi I. PE19.7/3
Kalemeera F. PE19.9/1
Kalluvya S. PE3.1/9
Kalvatchev Z. PS3/6
Kamarulzaman A. PE3.1/3
Kambugu A. PE10.2/1, PE14.8/1,
PE19.2/1, PE19.2/2
Kamya M. PE10.2/1
Kanis J. PE9.10/2
Kantipong P. PE3.1/3
Karafoulidou A. PE7.9/23
Karlsson A. PE3.1/2, PS6/1
Karpov I. PS6/1
Kasang C. PE3.1/9
Kasubi M.J. LBPE19.10/2
Katabira C. PE19.2/1
Katlama C. PE10.4/7, PE13.1/13,
PE13.2/7, PE18.1/4,
PE3.2/2, PE4.1/3,
PE4.2/1, PE7.2/5,
PE7.2/6, PE7.3/2,
PE7.3/9, PE9.1/3,
PE9.8/2, LBPS10/6,
PS12/2, PS6/1
Kaufmann G.R. LBPS5/7
Kazennova E. PE1.1/1, PE3.5/1,
PE4.4/1
Keane N.M. PE3.5/2
Kelleher A.D. PE7.9/11
Kelly M. PE7.3/7
Kenfak Foguena A. PE20.1/1
Kenny D. PE3.2/4
Kern P. PE9.9/2, PE9.9/3
Kerneis S. PE13.4/3
Kerr S. PS2/1
Keudel P. PE2.2/1, PE2.6/3
Khafizov K. PE4.4/1
Khanlou H. PS4/2
Khaykin P. PE6.5/1, PE9.2/1
Khienprasit N. PE13.1/7
Khoo S. PE4.1/7, PS12/5
Kiertiburanakul S. PE3.5/7, PE7.9/14
Kihembo C. PE19.2/2
Kihoro M.N. PE7.5/1
Kim E. PE10.1/9
Kimambo S.J. PE9.3/1
King M. PE10.1/1
King M.S. PE3.3/1, PE7.3/3
Kinkade A. LBPE1.4/4
Kiragga A. PE10.2/1
Kirchheiner J. PE4.1/9
Kirk O. PE18.1/4, PS3/3,
PS6/1, PS6/6, PS8/5,
PS8/6
Kirkby N. PS2/2
Kirschner M. PE7.9/3
Kirstetter M. PE9.3/5, PE9.7/7
Kissin D. PS9/2
Kivuyo S.L. LBPE19.10/2
Kiyegga A. PE3.1/6
Kjaer J. PE3.1/1, PE3.1/2
Klaassen T. PE4.1/9
Klauke S. PE7.3/1, PE9.2/1
Klausen G. PE3.3/3
Klein A. PE7.4/4
Klein C.E. PE4.1/4
Klimkait T. LBPE1.2/9
Klinische
Arbeitsgemeinschaft
AIDS Deutschland
(KAAD) PE13.2/3
Kluba-Wojewoda U. PE12.2/1
Knecht G. PE13.2/4, PE7.4/3,
PE9.7/1
Knechten H. PE12.5/1
Knobel Freud H. BPD1/8
Knobel H. PE3.5/6
Knol J. PE8.3/1
Knops E. PE3.2/4
Ko N.-Y. PE13.4/1
Kobayashi M. PE7.1/1
Koch S. PE13.4/5
Koegl C. PE7.9/19, PE7.9/20
Koelsch K.K. PE7.9/11
Koenig B. PE7.9/19
Koeppe S. PE7.9/19, PE7.9/20
Kollan C. PE7.4/7
Kolta S. PS5/3, PS5/4
Komolmit P. PS2/1
Kongola G.W.M. PE3.1/9
Koole O. PE9.6/4
Koppe S. PE3.3/3, PE7.3/11
Kordossis T. PE3.1/5, PE7.9/23
Korn K. LBPE1.2/9
Korner C. PE2.3/1, PS2/8
Kosa C. PS3/3
Kostrikis L.G. PE3.2/3
Kotler D. BPD2/4
Kourkounti S. PE3.1/5
Koussiapa I. PE3.2/3
Koutsilieri E. PE6.9/1
Kowalska J.D. PS6/6
Kowol S. PE11.4/1
Kozhevnikova G. PE2.4/1
Kozlowska J. PE11.5/3
Kozorez E.I. PE9.6/2
Kozyrev O. PE4.4/1
Kraemer S. PE3.1/7
Kramer B. PE2.3/1, PS2/8
Kravchenko A. PE13.1/5, PE2.4/1
Kreckel P. PE10.4/5, PE3.3/3
Kreplak G. PE9.7/7
Krishnappa V. PE20.5/2
Krolewiecki A. PS4/4
Kronborg G. PE20.3/1, PE3.1/1,
PE3.1/2
Kruk A. PS8/6, PS9/2
Krznaric I. BPD1/7
Kubesch V. PE2.4/3
Kubicka J. PE18.1/7, PE9.6/3
Kuehne A. PE7.4/7
Kuemmerle T.G. PE13.4/5
Kucherer C. LBBPD1/3
Kuhlmann B. PE18.4/5
Kukunda-Byobona C. PE19.9/1
Kulagin V. PE4.4/1
Kulasegaram R. PE12.1/2, PE13.1/2,
PE3.5/3, PE3.5/8,
PE7.9/10
Kulkarni D.G. PE20.5/2
Kumar A. PE20.5/2
Kumar S. PE7.2/8
Kummer S. PE2.6/3
Kuschak D. PE9.7/1
Kuttiatt V.S. PE11.1/1
LLa Martire G. PE6.7/1
Labarga P. PE7.9/12, PS2/7
Labbett W. PE13.1/9, PE20.6/1
Lacalle J. PS4/7
Lachau-Durand S. PE7.1/3, PE7.1/4
Lacheheb A. PE17.1/1
Lacombe K. PE9.1/1
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
228 Author Index
Lafuente C. PE13.1/4
Laga V. PE4.4/1
Lalezari J. PE7.2/4
Lambert-Niclot S. PE14.8/2, PE4.1/3,
PS12/2
Lammens L. PE7.1/4
Lamorde M. PE19.9/1
Lampe F.C. PE10.4/4
Landman R. PE3.1/7, PE3.2/2,
PE7.3/2, PE7.5/5
Landmann R. PE9.1/1
Lang J.M. PS6/4
Lang S. PS11/2
Lange J. BPD2/4
Langhans B. PE2.3/1
Lanoy E. PS5/4
Lantican L. PE3.3/4
Lanyero H. PE19.9/1
Larocca L.M. PE12.2/2
Larrouy L. PE3.2/2
Larsen M.V. PE20.3/1
Larson R.J. PE9.3/1
Lascoux C. PE1.4/3
Latini A. PS3/1
Latthaphasavang V. PE18.5/4
Lauenroth-Mai E. PE3.3/3
Lavreys L. PE7.3/4, PE7.3/7
Law M.G. PE3.1/3
Lawal A. PE10.1/1, PE7.3/3
Lawal A.A. PE7.5/3
Lawson-Ayayi S. LBPE9.7/8
Lazanas M. PE3.1/5, PE7.9/23
Lazar A. PE4.1/9
Lazor-Blanchet C. PE20.1/1
Lazrek M. PS12/3
Lazzarin A. LBPE13.2/10,
PE18.5/1, PE3.1/1,
PE9.2/5, PS6/3
Le Falher G. PE9.9/1
Le Moal G. PE14.2/1
Le Moing V. PE9.9/1
Leal M. BPD2/9, PE13.1/8,
PE18.4/6, PE2.1/1,
PE2.6/1, PE2.6/2,
PE2.8/1
Leavitt R. PE7.2/7
Lebrette M.-G. PE3.4/2
Ledergerber B. PE9.5/6, PS12/5,
PS5/2, PS6/6
Lee C.K.C. PE3.1/3
Lee E. BPD1/9
Lefebvre E. PE7.3/4
Lehmann C. PE6.5/1, PS12/7
Lemey P. PE1.1/2
Lengauer T. PE1.2/4, PE1.2/5
Lenz J. PS8/2
Leon J.A. BPD2/9
Leoncini F. PE7.4/6
Leopold L. PE7.1/2
Lepej S.Z. PE7.4/9
Lerma E. BPD1/8
Lescure F.X. PE3.1/4
Letranchant L. PE4.1/5
Levy-Bachelot L. PE9.1/3
Lewden C. PS6/2
Lewin S. PS2/1
Lewis M. PE3.4/8
Lewo K. PE3.1/5
Leyes M. PE18.1/3
Li L.-H. PE13.4/1
Li P.C.K. PE3.1/3
Lichtner M. PE11.1/3, PE6.7/1
Ligabue G. BPD2/2, PE9.5/10
Likanonsakul S. PE4.6/1, PE7.9/14
Lima L.A.A. PE10.1/5
Linka M. PE7.4/9
Liotier J.-Y. PE9.3/5, PE9.7/7
LIPO-AFRI PE9.1/1
Liporace R. PS4/2
Liu C. PE4.1/1
Liu W.-C. PE13.3/2, PE13.4/1
Liuzzi G. PE19.3/1
Livrozet J.M. PE4.1/2
Lo Caputo S. LS2/2
Lo Cicero M. PE1.2/8
Lo Presti A. PE17.2/2
Loderstadt U. PE13.4/2
Lodwick R. PE18.1/5
Loffredo M.R. PS2/5
Lohse A. PE2.6/3
Loizidou E.Z. PE3.2/3
Lonardo A. PS11/3
Lonati F. PE10.4/2
Longo N. PS4/3
Lopez A. PE18.1/2
Lopez Aldeguer J. PE9.2/3
Lopez Colomes J.L. BPD1/8
Lopez J. PE13.2/2
Lopez M. PE3.4/6
Lopez M.D. PE7.9/8
Lopez-Aldeguer J. PE1.2/7
Lopez-Aldeguer J. PS4/7
Lopez-Bernaldo-
de-Quiros J.C. PS4/6
Lopez-Bueno J. PE1.2/1
Lopez-Cortes L. PE13.1/8
Lopez-Cortes L.F. PE13.2/1
Lopez-Cortes L.F. PE2.6/2, PE2.8/1
Lorenzini P. PE18.4/4,
PE19.3/1
Loria P. PS11/3
Loschen S. LBBPD1/3
Lossa M. PE11.2/2
Losso M. PS8/5
Lostaunau G. PE18.5/6
Lovigu C. PE12.3/1
Lozano F. PE9.2/3, PS4/7
Lucas S. PE12.1/2
Lueangniyomkul A. PE4.6/1
Lukashov V. PE1.1/1
Lundgren J. PE18.1/4, PE3.1/2,
PS2/3, PS6/1, PS8/5
Lundgren J.D. PS6/6, PS8/6
Lupo S.H. PS4/3
Lupoli P. PE10.1/14, PE10.3/2,
PE18.5/7, PE19.1/4
Lutalo I. PE14.8/1, PE19.2/1,
PE19.2/2
Lutz T. PE7.3/11, PE7.4/3,
PE7.9/19, PE7.9/20,
PS2/4
Lyavala J. PE19.6/1
Lyimo J.J. PE9.3/1
Lymphoma Working
Group of COHERE BPD1/1
Lynen L. PE9.6/4
Lyons F. PS9/1
MM06-802 Study Team PE7.5/3
Mace M. PS12/3
Mach T. PE12.2/1
Machala L. PE3.1/1
Machmach K. PE2.6/2, PE2.8/1
Machouf N. PE4.1/3
Madeddu G. PE12.3/1
Madrid Cohort of HIV
Infected Children and
Adolescents PS9/5
Magafas N. PE3.1/5
Magenta A. PE9.10/1
Maggi P. PS11/4
Maggiolo F. LS2/2, PE10.1/3,
PE10.1/4, PE17.2/2,
PE3.4/10, LBPE4.3/5
Magiorkinis E. PE3.1/5
Magnani G. PE9.5/8
Magoni M. PE10.4/2
Mahlev-Guri K. PE10.1/2, PE9.7/6
Maiden T.M. PE3.5/2
Mair R. PE19.1/3
Majinge C. PE3.1/9
Mak C. BPD1/9
Makinson A. PE9.9/1
Maksimov S. PE13.1/5
Mall S. PE16.6/1
Mallal S. PE3.5/2
Mallolas J. BPD2/6, PE9.7/1
Mameli C. PS9/6
Mamidi R.N.V.S. PE7.1/3
Mamputu J.-C. BPD2/1
Manca N. PE3.1/8
Mancino P. PE9.5/9
Mancini M. LBPS11/6
Mandalia S. LBPE9.2/8
Mandel M. PS9/2
Manfredi R. PE11.2/1, PE11.5/1,
PE11.6/1, PE18.4/1,
PE18.4/2, PE19.1/2
Manfredini V. PS9/4, PS9/6
Mangelschots M. PE7.9/13
Mankatitham W. PE4.6/1
Mannazzu M. PE12.3/1
Mannens G. PE7.1/3
Manosuthi W. PE4.6/1, PE7.9/14
Mansinho K. PE20.4/6, PE20.7/1
Manzini L. PE13.2/5, PE13.2/6
Marasca G. PE10.1/7
Marcelin A.-G. PE14.8/2, PE4.1/3,
PE7.2/5, PE7.2/6,
PS12/2, PS12/3,
PS12/4
Marchetti G. PE9.10/1
Marconi P. PE10.1/10,
PE18.4/4
Marcotullio S. PE10.1/14, PE10.3/2,
PE18.5/7, PE19.1/4
Mardarescu M. PE11.6/4, PE9.2/4
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 229
Margot N. LBPE1.4/4
Maria G. PS3/1
Maricic A. PE19.8/1
Marinacci F. PS9/6
Marino A. PE7.9/9
Marniga G. PS3/1
Marques R. PE18.4/8
Marquez M. PE18.1/2, PE18.4/3
Marquez M. PE3.4/6
Marsh T. PE3.3/1
Marsolais C. BPD2/1
Martens B. PS8/2
Martens M. PE7.1/4
Martı-Belda P. PE9.6/5
Martin C. PE11.1/4, PE12.1/1
Martin D. LBPE7.2/9
Martın E. PE9.5/4
Martin J. PE2.4/2
Martin Prado S. PE10.1/6
Martin S. PE19.5/1, PE19.5/4,
PE19.5/5
Martinelli C. PS11/4
Martinelli L. PE3.4/7, PS11/4
Martınez Alfaro E. PE7.9/9
Martinez E. PE20.3/2, PE9.3/4,
PS10/2
Martinez J. PE18.1/6
Martinez Martinez C. PE10.1/6
Martinez-Marcos F. PE9.6/6
Martınez-Rodenas C. PE9.5/1
Marvan M. PE9.5/7
Mary-Krause M. PS11/2, PS5/3
Marzocchetti A. PE3.4/9
Marzolini C. PS12/5, PS5/2
Maschke M. PE6.9/1
Maserati R. PE7.5/2, PE7.9/21
Masia M. LBPE1.2/10
Masini G. PE3.4/7
Masquelier B. LBPE1.2/9, PS12/3,
PS12/4
Massetti A.P. PE6.7/1
Massetto B. PE9.6/1
Mastroianni C.M. PE11.1/3, PE6.7/1
Mata-Alcazar R. PE13.1/8
Mata-Marın J.A. PE13.1/11
Matarranz M. PE20.4/3
Mateo G. PE7.3/10
Mateo M.G. PE18.1/6
Matheron S. PS10/5
Mathews G. PS2/1
Matovu E. PE19.2/2
Matson M. PE4.1/1
Mauss S. LBPS10/6, PE13.2/3,
PE13.2/4, PE6.5/1,
PE7.4/3, PE9.7/1,
PE9.7/3
Mayanja F.Z. PE19.2/1
Mayberry C. PS4/5
Mayer H. PS12/1
Maylin S. PE1.4/3
Mayr C. PE3.3/3, PS2/4
Mazeron M.-C. PE13.1/4
Mazus A. PE13.1/6
Mazzetti M. PE7.4/6
Mazzocato V. PE10.1/7
McCarthy M.C. BPD1/9
McColl D.J. LBPE1.4/4
McCurdy L. PE7.2/4
Mcgovern R. PE3.4/8
McGrath D. PE7.3/8, LBPS11/6
Mckinnell J. PE7.4/5
McMichael A. PE2.4/2
McNeeley D. PE4.3/3
Mcnu*tt L.A. PS9/2
Medin G. PS9/5
Medrano J. PE7.9/12
Meier F. BPD2/5
Meini G. PE3.4/9
Melico-Silvestre A. PE12.5/2
Mellado M.J. PS9/3, PS9/5
Menard A. PS11/1
Menchero A. PE11.6/3
Mendez A.M. PE9.5/4
Mendez G. PE2.1/1, PE2.6/1
Mendez-Lagares G. PE13.1/8
Mengoni F. PE11.1/3, PE6.7/1
Mensa F.J. PE4.1/2
Mensing S. PE4.1/4
Menzaghi B. PE9.6/1
Meraviglia P. PE9.7/4
Mercadal L. PE10.4/7
Merino D. PE13.2/1, PE9.6/6
Merino E. PE9.2/2
Merry C. PE19.9/1
Mertens V. PE10.4/5
Meschiari M. PE13.2/5, PE13.2/6
Meuer E.K. PS12/7
Meyer A. PS3/4
Meyer T. PE13.4/2
Meyer-Olson D. PE2.2/1, PE2.6/3,
PE6.5/1, PS10/4
Meynard J.-L. PE3.1/7
Meztner K. PE3.1/6
Mian P. PE9.7/2
Michalik C. PE10.4/5, PE18.4/5,
PS12/6
Michalk M. PE2.3/1
Michaud S.-E. BPD2/1
Michlova V. PE7.1/3
Mignone F. PS9/4
Migrone H. PE7.3/11
Miguel B. PS4/5
Mihailescu R. PE11.6/4, PE9.2/4
Mikula T. PE11.5/3
Milinkovic A. PE3.5/6, PE9.7/1
Miller M.D. LBPE1.4/4
Miller R. PS8/5
Miller W. PS9/2
Mills E.J. LBPE18.5/8
Min S. PE7.2/4
Minaeva S. PE3.4/3
Minguez C. PE13.2/2, PE9.5/1
Minisci D. PE9.7/4
Mira J.A. PE13.2/1
Miralles D. PS4/4
Miranda A.C. PE20.7/1
Miro J. PS8/5
Miro J.M. PE18.1/4, PS8/4
Missy P. PS5/3, PS5/4
Mitsura V.M. PE9.6/2
Mkrtchyan A. PE7.9/5, PE7.9/6,
PE7.9/7
Mo T. PE3.4/8
Mocroft A. PE18.1/4, PE3.1/2,
PS2/2, PS2/3, PS3/3,
PS6/1, PS6/6, PS8/3,
PS8/4, PS8/5, PS8/6
Modena M.G. BPD2/2, PE9.5/10
Moecklinghoff C. PE19.5/2, PE3.4/1,
PE7.5/4
Moeremans K. PE19.5/1
Mohrmann G. PE13.4/2, PS5/5
Molina J.-M. PE1.4/3, PE13.4/3,
PE18.5/1, PE18.5/4,
PE7.2/2, PS12/2
Molina J.P. PE3.1/4
Moling O. PE9.7/2
Moll A. PE3.3/3
Montaner J. PS4/3
Montaner J.S.G. LBPE18.5/8
Montes B. PS12/3
Montes M.L. BPD2/3, PS4/6
Montolio F. LBPE1.2/10
Montserrat P. PE20.4/3
Mora M. BPD2/3, PE7.9/2
Mora S. PS9/4
Morand-Joubert L. PE3.1/7, PE7.2/6,
PS12/3, PS12/4
Moreau F. PE7.2/3
Morello J. PE7.9/12
Moreno A. PE18.1/4, PE7.4/10,
PE7.4/8, PE7.9/8,
PE9.6/5, PS3/7
Moreno O. PE9.2/2
Moreno S. PE18.4/6, PE3.5/6,
PE7.4/10, PE7.4/8,
PE7.9/8, PE9.6/5,
PS3/7
Morlat P. PE7.2/2
Morris S. PE12.1/2
Mortality Working
Group of COHERE PS6/2
Mortier E. BPD2/5
Moschella M. PE13.4/4
Moshkovich G. PE19.7/2, PE3.4/3
Mosthaf F. PE12.5/1, PE18.4/5,
PS3/4
MOTIVATE Tropism
Study Group PE3.4/8
MOTIVATE Tropism
Study Group, BC Centre
for Excellence in HIV,
Canada & Pfizer Inc. PE3.3/2
Mouly S. PE13.1/4
Mounoury O. PE7.9/1, PE7.9/15,
PE7.9/17, PS11/1
Mourmans B. BPD2/8
Moyle G. BPD2/1, PE4.3/2,
LBPE9.2/8, PS10/1,
LBPS10/6, LBPS11/6
Moyle G.J. LBPE7.2/9
Moyo R. PE11.6/3
Mrus J. PE10.1/12, PE4.1/8,
PE7.4/5
Mtei L.N. PE9.3/1
Mtonga V. PE19.7/4
Mueller A. PE7.4/3, PE9.7/1
Mueller M. PE7.9/19, PE7.9/20
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
230 Author Index
Mueller S.M. PE9.5/7
Muga R. PE20.3/2
Muganzi A.M. PE19.1/1
Mugavero M. PE7.4/5
Muhereza M. PE20.4/2
Mukuru Orphans and
PLWHAs Outreach
Intiative PE7.5/1
Mukwaya G. LBPE13.2/10
Mulcahy F. PS9/1
Muldoon E. PS9/1
Mulenga L.B. PE19.7/4
Mullen J. PE3.5/3, PE3.5/8
Muller A. PE9.2/1
Muller M. BPD1/2, PE10.4/5
Muller N. PE7.9/22
Munoz A. PE9.2/3, PS4/7
Munoz E. PE14.6/1, PE14.9/2
Munoz J. PE18.1/6, PE7.3/10,
PS4/7
Munoz M.A. PS9/3
Munoz Sanchez J. PE9.2/3
Munoz-Fernandez M.A. BPD2/9
Munteanu D. PE11.6/4
Munteanu D.I. PE9.2/4
Mura M.S. PE12.3/1
Muret P. PE4.1/5
Murillas J. PE18.1/3
Murphy S. PS9/1
Murray J. PE7.9/11
Murri R. PE10.1/14, PE10.1/7,
PE10.1/8, PE10.3/2,
PE12.2/2, PE18.5/7,
PE19.1/4, PS9/6
Mussini C. LS2/2, PE10.1/3,
PE13.2/5, PE13.2/6,
PE3.4/10
Muwonge T. PE19.2/1
Muyldermans G. PE3.2/1
Mwango A.J. PE19.7/4
NN2R Study Team PE4.6/1
Nadis� Group PE7.9/18
Nalugwa C. PE14.8/1
Naman E. LBPE19.10/2
Napolitano L. PE1.2/2
Narciso P. LS2/2, PE19.3/1,
PE3.4/10
Nardini G. PE7.5/2
Nattermann J. PE2.3/1, PS2/8
Naumann U. PE13.2/3
Navarra P. PE10.1/8, PE4.3/4
Navarro G. PS2/7
Navarro M. PS9/3
Navarro M.L. PS9/5
Navarro V. PE7.9/9, PS5/1
Navas E. PE7.9/8
Naylor C. PE3.3/1
Nazareth C. PE12.5/2
Ndulue N.A. PE20.4/1
Ndumbi P. PE2.6/4
Neaga E. PE11.6/4
Necsoi V.C. PE7.3/6, PS3/2
Neess-Engsig F. PS3/3
Negredo E. PE9.3/4
Negro P. PE9.5/3
Neibecker M. PE13.3/1
Nelson M. PE13.1/1, PE3.4/1,
PE7.2/8, PS12/1
Nere M.-L. PE1.4/3
Neri V. PE10.1/10,
PE10.1/11
Neukam K. PS2/7
Nevada Study Group BPD2/6
Nevin C. PE7.4/5
Ng J. PE4.1/4
Nguyen B.-Y. PE7.2/7
Nicastri E. PE19.3/1
Nichols G. PE7.2/4
Nicolini L. PE13.2/8
Nieto L. PE3.4/6
Nijhuis M. PE3.2/4
Nijs S. PE7.3/5, PE7.3/9
Nilkamhang S. PE7.9/14
Nischalke H.D. PE2.3/1, PS2/8
Noah C. PE13.4/2, PS5/5
Noertersheuser P. PE4.1/4
Nolting T. PE6.9/1
Norton M. PS4/5
Noto P. PS2/5
Nowotny B. PE7.9/3
Nozza S. PE9.2/5
Nulvesu L. PE10.1/4
Nuno E. PE18.1/2, PE18.4/3
Nuntachit N. PS8/1
Nurra G. PE17.1/2, PS2/5
OObadia M. PE3.1/7
Obel N. PE20.3/1, PS8/5
Obermeier M. PE13.2/9
Obermeier M.J. PE3.3/3
Obiefune M. PE11.1/2
Obry-Roguet V. PS11/1
Obua C. PE19.9/1
Obuku E.A. PE20.5/1
Ocana I. PE7.3/10
Occhineri E. PE9.5/3
Oette M. PE1.2/4
Ogden R. LBPE7.2/9
Ojeda G. PE13.2/1
Olaru I. PE11.6/4, PE9.2/4
Oliveira J. PE12.5/2
Oliveira M. PE3.4/4
Olshansky A. PE13.1/5, PE4.4/1;
PE13.1/6
Olutola A. PE11.1/2
Omar M. PE13.2/1
Omland L.H. PE20.3/1
Ondari R.O. PE7.5/1
Ong E. PE18.1/1
Oni B. PE11.1/2
Onyebuchi C. PE7.2/8
Opportunistic Infections
Working Group/
Collaboration of
Observational HIV
Epidemiological Research
Europe (COHERE) PS8/3, PS8/4
Opravil M. PE7.3/11, PE7.4/1,
LBPS5/7
Oprea C. PS2/6
Orani A. PE7.5/2
Orchi N. PE17.1/2
Ordonez J. PE9.3/4
OREY Study Group PS4/6
Orhan E. PE6.9/1
Orkin C. PE18.5/1, PS10/1
Orlando G. BPD2/2, PE9.10/2,
PE9.5/10, PS11/3
Ormaasen V. LBPE19.10/2
Orofino G. PE10.1/3, PS11/4
Oropeza V. PE3.4/6
Ortega E. PE1.2/7, PE13.2/2,
PE18.5/6, PE9.1/2
Ortu M. PE7.9/21, PE9.3/2,
PE9.7/4
O’Shea S. PE20.6/1, PE3.5/3,
PE3.5/8
Ossada C. PE3.4/2
Otelea D. PE11.6/4, PS2/6
Ouiminga M. PE9.1/1
Oussou A. PE19.7/1
Ouyahia A. PE17.1/1
Owen A. PE4.1/7, PS12/6
Oyomopito R. PE3.1/3
PPacanowski J. PE7.2/6
Pacheco Y. PE18.4/6, PE2.1/1,
PE2.6/2
Pacheco Y.M. PE13.1/8, PE2.6/1
Padilla S. LBPE1.2/10
Pagani L. PE9.7/2
Palacios R. PE18.1/2, PE18.4/3,
PE9.8/1
Palamara G. PE3.4/10
Palazon I. PE20.4/3
Palella F.J. PE9.5/10
Pallangyo K. PE9.3/1
Palleja S. LBPE7.2/9
Panagopoulos P. PE3.1/5
Pandey V.K. PE15.6/1
Panos G. PE3.1/5, PE7.9/23
Pans M. PS4/6
Panteleev A. PS8/5
Paolucci S. PE1.1/2
Papadopoulos A. PE3.1/5
Paparizos V. PE3.1/5, PE7.9/23
Paraschiv S. PE11.6/4
Paraskevis D. PE3.1/5, PE7.9/23
Paredes R. PS12/1
Parlic M. PE19.9/2
Parra J. PE18.4/6
Parruti G. PE4.3/4
Partisani M. PE4.1/5, PS11/2
Pascual R. PE13.1/8
Pascual-Pareja F. BPD2/3
Pasley M. PS4/5
Pasquau J. PE9.8/1
Passler W. PE9.7/2
Pastor O. PE7.9/8
Patel M. PE13.1/9
Patterson P. PS4/4
Pattery T. PE3.2/1
Pauli R. PE10.4/5
Pavie J. PE18.5/4
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 231
Pearce G. BPD2/7
Pearce H. PE18.5/1, PS10/1
Pedersen C. PS6/6
Pedrol E. BPD2/6, PE13.1/12,
PE7.9/16, PE7.9/2,
PE7.9/9, PE9.2/3,
PE9.5/4, PS4/7,
PS5/1
Pena A. PE1.2/1, PE1.2/7
Pena J.M. BPD2/3
Penaranda M. PE18.1/3
Pepanyan A. PE7.9/5, PE7.9/6
Peres S. PE20.4/6
Perez A. PE18.5/6
Perez Elıas M.J. PE9.6/5, PS3/7
Perez-Cachafeiro S. PS2/7
Perez-Elıas M.J. PE7.4/10, PE7.4/8
Perez-Elıas M.J. PE7.9/8, PS5/1
Perez-Molina J.A. PE3.5/6, PE7.9/2,
PE7.9/9
Perez-Tristancho M. PE11.6/3
Perfezou P. PE14.2/1
Perno C.F. LBPE1.2/9, PE17.2/2,
PE18.4/4, PE3.4/10,
PS12/1
Perre P. PE14.2/1
Peters L. PS2/2, PS2/3
Petkovic N. PE19.8/1
Petoumenos K. PE2.7/1
Petre V. PS3/1
Petrikkos G. PE3.1/5, PE7.9/23
Petrosillo N. PE19.3/1
Petry A. PE4.1/1
Petry R. PE7.9/20
Pettinato M.L. PE12.3/1
Peytavin G. PE14.8/2, PE3.2/2,
PE4.1/3, PE4.2/1,
PE7.3/2, PE7.5/5,
PS12/2
Pfister H. PE1.2/5, PE3.2/4
Phanuphak P. PE3.1/3
Phe T. PE9.6/4
Phillips A. PE18.1/5, PE3.1/1
Phillips A.N. PE10.4/4, PE3.1/2
Phillips R. PE13.1/9
Pialoux G. PE3.1/4, PE3.2/2,
PE3.4/2, PE7.2/3
Piatti P. PE9.2/5
Pico A. PE9.2/2
Piedoux S. PE4.1/5
Pierro P. PE10.1/10,
PE10.1/11
Pietrangeli A. PE13.4/4
Pietrogrande L. PE9.10/1
Pillay D. PE3.4/5
Pilloud M. PE3.4/2
Pilotti E. LBPE13.5/2
Pineda J.A. PE13.2/1
Pineiro C. PE18.4/8
Pineiro M.C. PE7.5/4
Pinol M. PS3/5
PINT Study Group PE7.9/11
Pinta A. PE3.1/7
Pinto C. PE12.5/2
Pinto I.P. PE10.1/13
Piroth L. PE4.1/5, PE7.2/2
Piscitelli S. PE7.2/4
Piselli P. BPD1/5
Pizzigallo E. PE9.5/9
Planelles M.V. PE9.5/1
Plantier J.-C. PE1.4/1
PLATO II Project
Team of COHERE BPD2/8, PE3.5/5
Platten M. PS12/6
Plettenberg A. PE13.4/2, PE4.1/2
Plum J. PE7.9/13
Pocaterra D. PE9.7/4
Podlasin R. PE18.1/7
Podlekareva D. PS8/5, PS8/6
Podsadecki T. PE10.1/1, PE10.4/3,
PE7.3/3
Podsadecki T.J. PE7.5/3
Podzamczer D. PE13.1/12, PE7.3/11,
PE9.3/4, PS10/3
Poggi S. PE11.2/2
Poirot C. PE14.8/2
Poizot-Martin I. PE7.9/18, PE9.1/3,
PS11/1
Pola M. PE12.3/1
Poljak M. PE7.4/9
Ponscarme D. PE18.5/4
Popova A. PE2.4/1
Portilla J. PE9.2/2
Portu J. PE18.4/7
Post F. PE9.5/5, PS8/5
Post F.A. PS5/6
Potenza C. PE11.1/3
Potthoff A. PS8/7
Potvin D. BPD2/1
Potyomina L. PE4.4/1
Poulakou G. PE3.1/5
Poulton M. PE9.5/5, PS5/6
Poveda E. PE7.9/12
Poynard T. PE13.1/13
Pozzi M. PE7.4/6
Pradel G. PE7.9/3
Prades M. PE14.8/2
Pradier C. PS2/3
Prasithsirikul W. PE7.9/14
Prati F. LS2/2
Prelutsky D. LBPS10/6
Premchand N. PE18.1/1
Prieto L. PE14.6/1
Prieto L.M. PE14.9/2
Prins M. PE18.3/1
Prommool V. PE4.6/1
Prosperi M. PE12.2/2, PE3.1/8,
PE9.11/1
Prosperi M.C.F. PE10.4/6, PE3.4/9
Prziwara D. PE3.3/3
Psychogiou M. PE3.1/5
Pugliese P. PE9.1/3
Puig T. PE13.1/12, PE9.2/3,
PS4/7
Pujol E. PE9.6/6
Pulido F. PE3.4/1, PE7.5/4,
PE7.9/2, PS4/1,
PS4/6
Pulido I. BPD2/9
Pulik P. PE9.6/3
Puls R.L. PE2.7/1
Puro V. BPD1/5, PE17.1/2
Puzzolante C. PE13.2/6
Pyziak-Kowalska K. PE18.1/7
QQuan Y. PE3.4/4
Quereda C. PE7.9/8, PE9.6/5,
PS3/7
Quinson A.M. PE4.1/2
Quintana Basterra A. PE10.1/6
Quirino T. LS2/2, PE8.3/1,
PS11/4
Quiros-Roldan E. PE10.4/2
RRabian C. PE13.4/3
Rachline A. PE18.5/4, PE7.3/5
Radecke K. PE13.5/1
Radian-Sade S. PE9.7/6
Radoi R. PE3.4/5, PS2/6
Radulescu M. PE11.6/4
Radun D. BPD1/7
Raffi F. PE14.2/1, PE7.9/1,
PE7.9/15, PE7.9/17,
PE7.9/18, PS11/1,
LBPS6/7
Raffo M. PE11.6/3
Ragazzoni E. PE10.1/8, PE4.3/4
Raggi P. BPD2/2, PE9.5/10
Raijmakers J. BPD2/4
Rakhmanova A. PE4.4/1, PS8/5,
PS8/6, PS9/2
Raleva S. PE6.1/1
Ramakrishna M. PE20.5/2
Ramos Amador J.T. PS9/5
Ramos J.M. LBPE1.2/10
Ramos J.T. PE14.6/1, PE14.9/2,
PS9/3
Randell P. LBPE9.2/8
Raoof A. PE7.1/3
Raper J. PE7.4/5
Rauch A. PE3.5/2
Rausch M. PS2/4
Razzolini F. PE3.4/9
Read P.J. PE12.1/2, PE7.9/10
Recordon-Pinson P. PS12/3
Reekie J. PS3/3
Reeves J.D. PE1.2/2
Reid S. PE19.7/4
Reisch A. PE9.5/7
Reiss P. LBPS10/6, PE18.1/4,
PS10/3
Reliquet V. PE14.2/1, PE7.9/1,
PE7.9/15
RESINA Study Group PE1.2/5
Rethwilm A. PE7.9/3
Reus S. PE9.2/2
Reuter S. PE1.2/4, PE1.2/5,
PE3.5/4
Reynaerts J. PE7.9/13
Reynes J. PE4.2/1, PE7.2/2,
PE9.9/1, LBPS6/7,
PS12/3
Rhame F. PE4.1/1
Rhee S.-Y. PE7.4/9
Rianda A. PS2/5
Ribas A. PE18.1/3
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
232 Author Index
Ribera E. PE7.3/10, PE7.9/9,
PE9.2/3, PE9.3/4,
PS4/7
Ricci E. PS11/4
Richter W. PE9.2/6
Rieke A. PS3/4
Riekstina V. PS8/5
Riera M. PE18.1/3
Rigothier C. LBPE9.7/8
Rimenti G. PE9.7/2
Rincon S. PE9.5/1
Rıos M.J. PE9.8/1
Rıos-Villegas M.J. PE13.2/1
Ripamonti D. LBPE4.3/5, PS4/1
Ristola M. PS6/6
Rittweger M. PE11.4/1
Rivas I. BPD2/9
Rivas P. PE7.9/2
Rivero A. PE9.8/1, PS4/6
Rizzardini G. PE10.4/6, PE8.3/1
Roberts S. PE3.5/2
Robinson J. PS9/2
Robinson Morgan K.Y. PE7.5/3
Robinson P. PE4.1/2
Robledano C. LBPE1.2/10
Robles M. PE11.2/2
Roca B. PE9.2/3, PS4/7
Rockstroh J. BPD1/7, PE13.2/3,
PE13.3/1, PE13.5/1,
PE2.3/1, PE6.5/1,
PE7.2/7, PE7.4/2,
PE7.4/4, PS2/2,
PS2/3, PS2/4, PS2/8,
PS3/4, PS10/3
Rodallec A. PE7.9/15, PE7.9/17
Rode R. PE10.1/1
Rodes B. PE1.1/2
Rodrigo A. PE3.5/6
Rodrıguez-Gomez F. PE9.6/6
Rodriguez-Novoa S. PE7.9/12
Rodriguez-Sagrado M.A. PE7.9/8
Rodwick B. PE7.3/4
Rogez S. PS12/4
Rojo P. PS9/3
Romerio F. PS12/7
Ropers D. PE9.5/7
Roquebert B. PE1.4/1
Rosales J. PE9.3/4
Rosenthal E. PS6/4
Rosignoli D. PE9.7/5
Ross B. BPD1/2
Rossi R. BPD2/2, PE6.7/1,
PE9.5/10
Rosso R. PE10.1/4, PE13.2/8
Roux C. PS5/3, PS5/4
Rouzioux C. PE1.4/1
Roverato A. BPD2/2, PE9.10/2,
PE9.5/10, PS11/3
Rozenbaum W. PE18.5/4
Rozenberg S. PS5/3, PS5/4
Rubio R. PS4/6
Ruelle J. PE1.1/2, PS10/5
Ruffault A. PS12/3
Ruız-Contreras J. PS9/3
Ruiz J. PE18.1/2, PE18.4/3
Ruiz S. PE7.9/16, PE9.5/4
Ruiz-Mateos E. BPD2/9, PE2.6/2,
PE2.8/1
Rumyantseva O. PE1.1/1
Rusconi S. PE1.2/8, PE9.6/1
Ruxrungtham K. PE7.9/14, PS2/1
Ryan M. PE19.9/1
Ryan R. PE10.1/12, PE4.1/8
SSaag M. PE7.4/5
Saavedra J. PS9/3
Sabatakou H. PE7.9/23
Sabin C. PE18.1/5, PS6/5
Sabin C.A. PE10.4/1
Sabranski M. BPD1/2, PS3/4
Saez de Adana E. PE18.4/7
Sahraoui S. PE7.3/2
Salami O. PE20.4/1, PE7.7/1
Salee P. PE13.1/7
Saleh A. PE20.4/1
Salehian S. PE13.1/1
Salota R. PS5/6
Salpietro S. PE9.2/5, PS6/3
Sambatakou H. PE3.1/5, PS6/6
Sambeat M.A. PE18.1/6
Sampalis J. PS4/3
San Jose B. BPD2/3
San Miguel S. PE18.4/7
Sanchez B. BPD2/9
Sanchez E. PE18.5/6
Sanchez J. PE9.2/2
Sanchez T. PS4/7
Sanchez T. PE9.2/3
Sanchez V. LBPE1.2/10
Sanchez-Conde M. PE9.8/1
Sangeda R.Z. PE7.4/9
Sankar N. PE18.1/1
Santoro Lopes G. PE10.1/5
Santoro M.M. PE3.4/10
Santos I. PE9.8/1
Santos J. PE18.1/2, PE18.4/3,
PE9.8/1, PS2/7
Sanvisens A. PE20.3/2
Sanz Moreno J. PE11.6/2
Sapirstein J. LBPE7.2/9
Saraiva J. PE12.5/2
Sarfo F.S. PE13.1/9
Sari-Chaaf Z. PE4.2/1
Sarmento A. PE18.4/8
Sasse A. PE7.7/2
Sasset L. PE9.9/4
Sato A. PE7.1/1
Sauerbruch T. PE2.3/1, PS2/8
Saumoy M. PE9.3/4
Sauzer-Chirat F. PE14.2/1
Sauzullo I. PE11.1/3, PE6.7/1
Scalise G. PE10.4/6, PE9.5/8,
PS11/5
Schapiro J.M. LBPE1.2/9
Scarcella C. PE10.4/2
Schaft N. PE2.4/3
Schaub-Koch C. PE9.5/7
Schauseil S. PE9.7/1
Scheller C. PE3.1/9
Schenone E. PE13.2/8
Scherrer A. PE7.4/1
Schewe K. PE13.2/3, PE13.4/2,
PS5/5
Schiaroli E. PE9.7/5
Schiavini M. PE9.7/4
Schifano E. BPD1/5
Schipani A. PE4.1/7
Schirmeister T. PE7.9/3
Schlote F. PE3.3/3
Schmidt A.J. BPD1/7
Schmidt R.E. PE18.4/5, PE2.2/1,
PE9.3/3, PS10/4
Schmidt W. PE3.3/3, PE7.9/19,
PE7.9/20
Schmidt-Wieland T. PE9.9/2
Schmiedel S. PE2.6/3
Schmutz G. PE9.7/1, PE9.7/3
Schneider A. PS5/5
Schneider L. PE13.2/7, PE7.2/5,
PE7.2/6, PE9.8/2
Schneider V. PE3.1/4, PE3.4/2,
PE7.2/3
Schnepf N. PE13.1/4
Scholler-Gyure M. PE4.3/1
Scholten S. PE18.4/5
Schomig E. PE4.1/9
Schrager H. PS4/2
Schroder S. PE11.6/2
Schuler C. PE3.3/3
Schuler G. PE2.4/3
Schulte D. PE2.3/1, PS2/8
Schulze zur Wiesch J. PE2.6/3, PE6.5/1
Schurmann D. PS3/4
Schwarze-Zander C. PE13.3/1, PE7.4/2,
PE7.4/4
Schwenk A. PE10.4/1
Sciarrone M.R. PS2/5
Scieux C. PE13.4/3
Scognamiglio P. PE10.4/6, PE17.1/2,
PS2/5
Scrivo R. PE11.1/3
Seclen E. PE7.9/12
Secondo G. PE13.2/8
Seddiki N. PE7.9/11
Seeringer A. PE4.1/9
Sekar V. PE4.1/8
Selleri M. PE17.1/2
Sellier P. PE13.1/4
SENDIH Group PE17.1/2
Serebrovskaya L. PE2.4/1
Serna C. PE9.2/2
Serrano M. PE9.5/1
Serrano O. PE3.5/6, PS4/6
Serrao R. PE18.4/8
Sethi A. PE10.2/1
Sette P. PE10.1/10,
PE10.1/11, PE18.4/4,
PE19.3/1
Shaw B. PE3.1/6
Shen J. BPD1/9
Sheppard L. PE7.3/8
Sherchan S. PE19.1/3
Sherr L. PE10.4/4
Sherwood R. PS5/6
SHIELD Study Team PE7.2/1
Shilova O. PE19.7/2
Shuber B. PE14.8/2
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 233
Sias C. PE17.1/2
Siccardi M. PE4.1/7
Sichtig N. PE1.2/5, PE3.5/4
Siciliano V. PE12.2/2
Siehl J. BPD1/2, PS3/4
Sierra S. PE1.2/5
Sierra-Madero J. PS4/3
Sighinolfi L. PE10.1/3, PE7.5/2
Silva C. PE20.4/6
Simon A. PE4.1/3, PS11/2
Simon F. PE1.4/3, PE3.1/4
Simoneau G. PE13.1/4
Simonova I. PE13.1/6
Simonyan V. PE7.9/4
Simpson K.N. PE10.4/3
Sirera G. PS3/5
Sirianni F. PE1.2/8
Sirisanthana T. PE3.1/3
Sirivichayakul S. PE3.1/3
Sista P. PE3.2/1
Sizmann D. PE1.4/1
Skaletz-Rorowski A. PE10.4/5, PE18.4/5
Sklar P. PE7.2/7
Skrahina A. PS8/5
Skroza N. PE11.1/3
Slama L. PE7.2/3, PE9.1/1,
LBPS10/6
Sloan L. PE7.2/4
Smets E. PE19.5/3, PE19.5/5
Smirnova S. PE13.1/5
Smit E. PE20.6/1
Smith C.J. PE10.4/4
Smith J. PE3.1/3
SNODO Study Group PE7.5/2
Sodo M.R. PE9.5/2, PE9.5/3
Soeung S. PE9.6/4
Sole E. BPD1/8
Sollima S. PE9.6/1
Song I. PE7.2/4
Sonnerborg A. PE3.1/8
Sonnerborg A. LBPE1.2/9, PE7.4/9
Soorapanth S. PE19.5/3
Sopper S. PE6.9/1
Soriano V. PE1.1/2, LBPE1.2/9,
PE7.3/11, PE7.9/12,
PS10/3, PS10/5,
PS2/2, PS2/3, PS2/7
Sorli Redo L. BPD1/8
Sornı P. PE18.5/6
Sotgiu G. PE7.5/2
Sotnikov V. PE4.4/1
Soto B. PE14.9/2
Soulban G. BPD2/1
Soulie C. PE4.1/3, PE7.2/5,
PS12/2, PS12/3
Souza C.A.P. PE10.1/5
Sozio F. PE4.3/4
Spagnuolo V. PS6/3
Spengler U. PE13.3/1, PE2.3/1,
PS2/8
Spanish Cohort of
Mother-to-Child
Transmission PE14.6/1
Spinosa S. PS4/4
Spire B. PE7.2/2
Spiri D. PS9/6
Spittaels K. PE4.3/1
Spreen W. PE7.1/1
Spriewald B. PE9.5/7
Squires K. PE10.1/12,
PE7.3/8
Srasuebkul P. PE2.7/1
Ssali L. PE19.6/1,
PE19.7/3
Ssewankambo F. PE14.8/1
St. Clair M. PE7.2/1
Stanczak G. PE7.4/9
Standker L. PS10/4
Stankov M.V. PE9.3/3
Stano F. PE9.5/2, PE9.5/3
Staszewski S. PE18.4/5
Stawiski E. PE1.2/2
Steffan E. BPD1/4, PE18.5/3,
PE20.4/5
Steffgen J. PE4.1/2
Stein L. PS8/2
Stellbrink H.-J. PE13.4/2, PE7.9/19,
PE7.9/20, PS10/1,
PS2/4, PS5/5
Stenger S. PE9.9/2
Stentarelli C. PS11/3
Stephan C. PE9.2/1
Stern J. PE4.1/2
Sterrantino G. PE7.4/6
Stevens M. PE7.1/2
Sthoeger Z. PE10.1/2, PE9.7/6
Sticchi Damiani A. PE9.5/3
Stich A. PE3.1/9
Stitou H. PE13.2/7, PE9.8/2
Stocker H. PE11.4/1
Stoehr A. PE13.2/4
Stojanovic M. PE19.8/1, PE19.9/2
Stoll M. PE10.4/5, PE13.5/1,
PE19.5/2, PE19.5/3,
PE19.5/4, PS10/4
Storto A. PE3.2/2
Streinu Cercel A. PE11.6/4, PE9.2/4
Stringer E. PE19.7/4
Stringer J. PE19.7/4
Stucchi S. PS9/4
Study Group on
Sexual Risk Factors
for Hepatitis C BPD1/7
Stuyver L. PE1.2/6
Suarez-Lozano I. PE11.6/3, PE7.9/2,
PE7.9/9, PE9.2/3,
PS4/7
Suchard M. PE1.1/2
Sukasem C. PE3.5/7
Sungkanuparph S. PE13.1/3, PE3.1/3,
PE3.5/7, PE4.6/1,
PE7.9/14
Suntisuklappon B. PE7.9/14
Supparatpinyo K. PE13.1/7, PS8/1
Supuran C.T. PE1.2/8
Surah S. PS9/1
Suter F. PE10.1/3, LBPE4.3/5
Svicher V. PE17.2/2
Swiecki P. PE9.6/3
Swiss HIV Cohort Study PS12/5, LBPS5/7,
PE9.5/6
Szlavik J. PE8.1/1
TTabuti J.R.S. PE19.9/1
Tagliabue L. PE9.10/1
Taıeb A. PS10/5
Taisheva L. PE19.10/1
Tamalet C. PS12/3, PS12/4
Tamburrini E. PE10.1/7, PE10.1/8
Tan P.Y. PE18.1/1
Tana M. PE9.5/2, PE9.5/3
Tantanathip P. PE4.6/1
Tapiz A. PE13.1/12
Tardei G. PS2/6
TASER-M PE3.1/3
Tasias M. PE7.9/16, PE9.5/4,
PS5/1
Taubald A. PE9.5/7
Tavares M. PE18.4/8
Taylor A. PE19.7/4
Taylor J. PE4.3/2,
LBPE9.2/8
Taylor S. PE7.3/11, PS10/3
Teira R. PE7.9/2, PE7.9/9,
PE9.2/3, PS4/7
Tellez M.J. PE1.2/7
Tenore S.B. PE10.1/13
Teofili L. PE12.2/2
Teppler H. PE7.2/7
Terron A. PE9.2/3, PE9.8/1
Terron A. PS4/7
Tetradov S. PS2/6
Tettoni C. PE4.1/7
Thai S. PE9.6/4
Than S. LBPE13.2/10
Thawornwan U. PE4.6/1
The Y.-H. PS10/4
Theodoridou M. PE3.1/5
Theys K. PE7.4/9
Thielen A. PE1.2/4, PE1.2/5,
PE3.4/8
Thoden J. BPD1/2
Thomas R. PE4.1/3
Thomssen A. PE2.6/3, PE6.5/1
Thongyen S. PE4.6/1, PE7.9/14
Tiomon A. PE19.7/1
Toibaro J. PS8/5
Tolksdorf F. PS2/8
Toma J. PE1.2/2
Tomaka F. PS4/4
Tong C.Y. PE13.1/2
Tong W. PE20.6/1, PE3.5/3
Tonkikh O. PE4.4/1
Tonoukouen C.L. PE19.7/1
Torrens M. PE20.3/2
Torres R. PS5/1
Torres-Tortosa M. PE13.2/1
Torti C. PE10.4/2, PE10.4/6,
PE7.4/9, PE8.3/1
Tossing G. PE13.2/3
Tosti A. PE3.4/7
Touloumi G. PE7.9/23
Tourret J. PE18.1/4
Tozzi V. PE19.3/1
Trabaud M.-A. PS12/3
Traeder C. PE11.4/1
Tran G.M.K. PE5.10/1
Trapp S. PE1.2/4
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
234 Author Index
Trein A. PE7.9/19, PE7.9/20,
PE9.9/3
Trevino S.C. PE3.4/6
Tropism Study Group PE1.2/6
Trotta M. PE7.4/6
Trotta M.P. PE10.1/10,
PE10.1/11, PE10.1/3,
PE18.4/4, PE19.3/1
Trullas J.C. PE18.1/4
Tschochner M. PE3.5/2
Tsekov I. PS3/6
Tsertsvadze T. PE17.2/1
Tsiang M. LBPE1.4/4
Tsoukas C. PE2.6/4
Tsybakova O. PE4.4/1
Tubiana R. PE10.4/7, PE13.2/7,
PE14.8/2, PE7.2/5,
PE7.2/6, PE9.8/2
Tuma P. PE10.1/13, PS2/7
Tumanov A. PE4.4/1
Tundo P. PE9.5/3
Tural C. PE13.3/1, PS3/5
Tutschkus M. PE9.2/1
Tvaroha S. PE9.3/1
UUcciferri C. PE9.5/9
Udegboka N.T. PE19.4/1, PE20.4/4
Uglietti A. PE7.9/21
Ujhelyi E. PE8.1/1
UK CHIC Study
Steering Committee PE10.4/1
UK Collaborative HIV
Cohort (CHIC) Study PS6/5
Ul’janina N. PE4.4/1
Ulmer A. PE9.9/3
Ummard K. PS2/4
Un P. PE9.6/4
Underwood M. PE7.1/1
Uneken P. PE9.5/4
Unger S. PE13.4/2
Ungureanu E. PS2/6
Uy J. PE7.3/8
VVabret A. PS12/3
Valadas E. PS10/5
Valantin M.-A. PE10.4/7, PE13.1/13,
PE7.2/6, PE9.8/2,
PS5/3, PS5/4
Valantin M.A. PE13.2/7, PE7.9/18
Valdez H. PE3.4/8, PS12/1
Valenti D. PE17.2/2
Valentino F. PE9.5/3
Valero S. BPD2/6
Valesini G. PE11.1/3
Valin N. PE7.2/6
Vallecillo G. BPD1/8, BPD2/6,
PE20.3/2, PE9.2/7
Valluri S.R. LBPE13.2/10
Valsecchi L. PS11/4
Van de Casteele T. PE7.3/7
van de Vijver D. PE3.1/8, PE3.2/3
van Delft Y. PE7.5/4
Van den Eynde E. PE7.3/10
Van der Borght K. PE3.2/1, PE3.3/4
Van der Ryst E. PS12/1
van Beckhoven D. PE7.7/2
van Eeden A. LBPS10/6
van Heeswijk R. PE4.3/3, PE7.1/2
Van Houtte M. PE3.2/1
Van Laethem K. PE3.1/8, PE7.4/9
van Lunzen J. BPD1/2, PE2.6/3,
PE6.5/1, PS6/1,
PS12/7
Van Marck H. PE1.2/6
van Schaik J. PE8.3/1
van Sighem A. LS2/1, PS10/5
van Veen M. PE18.3/1
van Velsen F. PE7.1/4
Van Walle I. PE3.2/1, PE3.3/4
Van Wanzeele F. PE7.9/13
Van Wijngaerden E. PE7.3/7, PE7.4/9
Vandamme A.M. PE1.1/2, PE7.4/9
Vandamme A.-M. LBPE1.2/9
Vandekerckhove L. PE1.2/6, PE3.2/4,
LBPE1.2/9
Vanden Abeele C. PE7.3/4
Vanig T. PE7.2/1, PS4/2
Van-Steenberge E. PE4.1/2
van’t Land B. PE8.3/1
Vanveggel S. PE7.1/2
Varlova L. PE19.7/2
Vasiliev A. PE1.1/1
Vasilyev A. PE3.5/1
Vassallo F. PE10.4/2
Vaz-Pinto I. PE18.5/2
Vecchiet J. PE9.5/9
Vedovelli C. PE9.7/2
Venkatesh D. PE20.5/2
Vera E.J. PE9.5/1
Vera J. PE18.5/2
Vergara A. PE9.2/3, PS4/7
Verheyen J. PE3.2/4
Verhofstede C. PE1.2/6, PE3.2/4,
PE7.4/9, PE7.9/13
Vernazza P. PE7.4/1, PS12/5,
PS5/2, LBPS5/7
Vescini F. PE9.10/2
Viard J.-P. PE3.1/1, PS5/3, PS5/4
Viciana P. PE13.1/8, PE18.4/6,
PE2.6/2, PE2.8/1,
PE9.2/3, PS4/7
Vidal F. PE18.4/6, PE9.2/3,
PS4/7
Vidal M. PE7.9/16
Videla S. PS3/5
Vietorisz I. PE8.1/1
Vigano A. PS9/4, PS9/6
Vignale F. PE9.5/9
Vilchez R. PE7.2/8
Villacian J. PE3.3/4
Villalonga C. PE18.1/3
Villanueva S. PE18.5/6
Villar Garcıa J. BPD1/8
Vincent T. PE13.1/13
Vinci C. PE9.2/5
Virolab, Euresist, Chain PE3.1/8
Vis P. PE4.1/8
Visco F. PE9.2/5
Viscoli C. PE10.1/4, PE13.2/8
Vispo E. PE7.9/12
Vitek C. PS9/2
Vitiello P. PS11/4
VL Evaluation Study
Group PE20.6/1
Vlassi C. PE17.1/2
Vlatkovic Ilic V. PE19.9/2
Vogel M. BPD1/7, PE13.2/3,
PE13.3/1, PE2.3/1,
PE7.4/2, PE7.4/4,
PS2/2, PS2/3, PS2/4
Voide C. PE20.1/1
Voigt E. PE13.2/3
von Reyn F. PE9.3/1
von Schloesser F. PE10.1/14, PE10.3/2,
PE18.5/7, PE19.1/4
Voronin E. PE4.4/1, PS9/2
Vriesema A. BPD2/4, PE8.3/1
Vrouenraets S.M.E. LBPS10/6
Vucinic M. PE19.9/2
Vujnovic L. PE19.8/1
Vujnovic M. PE19.8/1
Vukotic O. PE19.9/2
Vullo V. LS2/2, PE11.1/3,
PE13.4/4, PE4.3/4,
PE6.7/1, PE9.5/8
Vvedenskaya E. PE19.7/2
Vyncke V. PE4.3/1
WWaako P. PE19.9/1
Wagner J. PE4.1/1
Wahlers K. PE9.9/2, PE9.9/3
Waibale P.C. PE20.4/1
Wainberg M.A. PE3.4/4
Waldhauser L. PE4.1/2
Walli R. PE18.4/5
Walter H. LBPE1.2/9
Wanchu A. PE11.1/1
Wandera B. PE10.2/1
Wang J. PE18.5/1
Wang M. LBPE1.4/4
Wang-Smith L. LBPE7.2/9
Wanyama J.N. PE19.2/1
Warren D.R. BPD2/7
Wasmuth J.-C. BPD1/2, PE13.3/1,
PE7.4/2, PE7.4/4
Waters L. PS12/1
Weber R. PE11.5/2, PE9.5/6,
PS12/5, PS5/2
Weiss L. PE7.5/5
Weissbrich B. PE3.1/9
Welling G. PE8.3/1
Wellmann E. PE13.2/4
Wenning L. PE4.1/1
Wensing A. PE3.2/4
Wensing A.M.J. LBPE1.2/9, PE7.4/9
Werner B. PE10.1/2, PE9.7/6
Wiboonchutikul S. PE3.5/7
Wiercinska-Drapalo A. PE11.5/3
Wilkin A. PE7.3/7
Willems B. PE7.1/4
Willig J. PE10.1/9, PE7.4/5
Willmann M. PE9.9/3
Wilton B. PS4/3
Winston A. PS6/5
Winters B. PE3.3/4
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
Author Index 235
Winzer R. PE3.5/4
Wirden M. PE4.1/3
Wirtz V. LBPS11/6
Wit F.W.N.M. LBPS10/6
Witek J. PE4.1/6, PE4.3/1,
PE7.3/5, PE7.3/9
Wolf E. PE12.5/1,
PE7.9/20
Wolf T. BPD1/2, PS3/4
Wong T. PE13.1/2
Wongprasit P. PE13.1/3
Wood D. PE4.1/1
Woodward W.C. PE7.5/3
Wu C.-H. PE13.3/2, PE13.4/1
Wu J. PE4.1/2
Wu P.-Y. PE13.3/2, PE13.4/1
Wunsche T. PE9.2/6
Wyen C. BPD1/2, PE4.1/9,
PS12/6, PS3/4
XXiridou M. PE18.3/1
Xu H. PE3.4/4
YYang R. PE7.3/8, LBPS11/6
Yau L. PE7.2/1
Yazdanpanah Y. PE7.9/18
Ye J. PE7.4/5
Yeni P. PE3.2/2, PE4.2/1
Yerly S. PE7.4/1
Yong C.L. PE4.1/2
Yoshinaga T. PE7.1/1
Young B. PE7.2/1
Young J. PE7.4/1
ZZaccarelli M. PE10.1/10,
PE10.1/11, PE18.4/4,
PE19.3/1,
PE3.4/10
Zajeganovic J. PE19.9/2
Zakari U. PE7.7/1
Zamora F.X. BPD2/3
Zannoni G. PS3/1
Zaunders J.J. PE7.9/11
Zazzi M. LBPE1.2/9, PE3.1/8,
PE3.4/10, PE3.4/7,
PE3.4/9, PE7.4/9
Zedlack C. PS8/2
Zeinalipour-Yazdi C. PE3.2/3
Zeinecker J. PE7.2/8
Zhao J. PE7.2/7
Zhong X. PE3.4/8
Zielinska-Skowronek M. PE2.2/1
Zilmer K. PS6/1
Zimmermann R. LBBPD1/3
Zinsou R. PE7.2/5
Zizza A. PE9.5/2, PE9.5/3
Zoe-Powers A. PE10.1/9
Zona S. BPD2/2, PE9.10/2,
PE9.5/10, PS11/3
Zoufaly A. PE13.5/1
Zucchi P. PS10/1
Zuccotti G. PS9/4
Zuccotti G.V. PS9/6
Zucman D. BPD2/5, PE7.5/5
Zung A. PE9.7/6
Zweigner J. PS8/2
ª 2009 The AuthorsJournal compilation ª 2009 British HIV Association, HIV Medicine, 10 (Suppl. 2), 222–236
236 Author Index
